Library Subscription: Guest
Critical Reviews™ in Neurobiology

Published 3 issues per year

ISSN Print: 0892-0915

ISSN Online: 2375-0014

SJR: 0.121

Cognitive Impairment in Schizophrenia Is the Core of the Disorder

Volume 14, Issue 1, 2000, 21 pages
DOI: 10.1615/CritRevNeurobiol.v14.i1.10
Get accessGet access

ABSTRACT

Patients with schizophrenia exhibit an exceedingly wide range of symptoms from a variety of domains. The cardinal features are abnormal ideas (such as delusions); abnormal perceptions (such as hallucinations); formal thought disorder (as evidenced by disorganized speech); motor, volitional, and behavioral disorders; and emotional disorders (such as affective flattening or inappropriateness). In addition to these diverse, and sometimes bizarre symptoms, it has become increasingly apparent that the disorder is, to variable degrees, accompanied by a broad spectrum of cognitive impairments. This review addresses the question of whether the cognitive deficits seen in schizophrenic patients are the core features of the disorder. In other words, we explore whether schizophrenia is best characterized by symptoms or cognitive deficits (we suggest the latter) and moreover, whether there is a specific cognitive deficit profile that may assist in diagnosis. First, we discuss what the cognitive deficits are. Then we address in turn the reality, frequency, predictive validity, specificity, course and susceptibility to neuroleptic effects of these cognitive impairments. In brief, we argue that various cognitive deficits are enduring features of the schizophrenia illness, that they are not state-related and are not specific to subtypes of the illness, and, more specifically, that working memory and attention are characteristically impaired in patients with schizophrenia, irrespective of their level of intelligence. Last, we conclude that problems in these cognitive domains are at the very core of the dysfunction in this disease.

CITED BY
  1. Lipina Tatiana V., Palomo Valle, Gil Carmen, Martinez Ana, Roder John C., Dual inhibitor of PDE7 and GSK-3 – VP1.15 acts as antipsychotic and cognitive enhancer in C57BL/6J mice, Neuropharmacology, 64, 2013. Crossref

  2. Turner Karly M., Young Jared W., McGrath John J., Eyles Darryl W., Burne Thomas H.J., Cognitive performance and response inhibition in developmentally vitamin D (DVD)-deficient rats, Behavioural Brain Research, 242, 2013. Crossref

  3. Taylor Adam R., Taylor Sara B., Koenig James I., The involvement of Type II Neuregulin-1 in rat visuospatial learning and memory, Neuroscience Letters, 531, 2, 2012. Crossref

  4. Ben-Zeev Dror, Drake Robert E., Corrigan Patrick W., Rotondi Armando J., Nilsen Wendy, Depp Colin, Using Contemporary Technologies in the Assessment and Treatment of Serious Mental Illness, American Journal of Psychiatric Rehabilitation, 15, 4, 2012. Crossref

  5. Ferrer i Cancho R., Zipf's law from a communicative phase transition, The European Physical Journal B, 47, 3, 2005. Crossref

  6. Zhuo Kaiming, Lu Yun, Yang Zhiliang, Fan Xiaoduo, Song Zhenhua, Liao Liwei, Ji Chenfeng, Zhu Dianming, Yu Shunying, Yan Chao, Chan Raymond C.K., Goff Donald C., Xu Yifeng, Liu Dengtang, Prospective memory performance in patients with drug-naïve, first-episode psychosis, Schizophrenia Research, 143, 2-3, 2013. Crossref

  7. Puig M. Victoria, Miller Earl K., The Role of Prefrontal Dopamine D1 Receptors in the Neural Mechanisms of Associative Learning, Neuron, 74, 5, 2012. Crossref

  8. Han Kiwan, Young Kim In, Kim Jae-Jin, Assessment of cognitive flexibility in real life using virtual reality: A comparison of healthy individuals and schizophrenia patients, Computers in Biology and Medicine, 42, 8, 2012. Crossref

  9. Lee Heekyung, Dvorak Dino, Kao Hsin-Yi, Duffy Áine M., Scharfman Helen E., Fenton André A., Early Cognitive Experience Prevents Adult Deficits in a Neurodevelopmental Schizophrenia Model, Neuron, 75, 4, 2012. Crossref

  10. Lewis David A., Mirnics Karoly, Transcriptome alterations in schizophrenia: disturbing the functional architecture of the dorsolateral prefrontal cortex, in Functional Genomics and Proteomics in the Clinical Neurosciences, 158, 2006. Crossref

  11. Stolz Erin, Pancholi Krishna M., Goradia Dhruman D., Paul Sarah, Keshavan Matcheri S., Nimgaonkar Vishwajit L., Prasad Konasale M., Brain activation patterns during visual episodic memory processing among first-degree relatives of schizophrenia subjects, NeuroImage, 63, 3, 2012. Crossref

  12. Anticevic Alan, Repovs Grega, Krystal John H., Barch Deanna M., A broken filter: Prefrontal functional connectivity abnormalities in schizophrenia during working memory interference, Schizophrenia Research, 141, 1, 2012. Crossref

  13. Müller U., Ullsperger M., Hammerstein E., Sachweh S., Becker T., Directed forgetting in schizophrenia, European Archives of Psychiatry and Clinical Neuroscience, 255, 4, 2005. Crossref

  14. Cannon Christopher E., Puri Vanita, Vivian Jeffrey A., Egbertson Melissa S., Eddins Donnie, Uslaner Jason M., The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeys, Neuropharmacology, 64, 2013. Crossref

  15. Pompili Assunta, Arnone Benedetto, Gasbarri Antonella, Estrogens and memory in physiological and neuropathological conditions, Psychoneuroendocrinology, 37, 9, 2012. Crossref

  16. Bortolozzi A., Díaz-Mataix L., Toth M., Celada P., Artigas F., In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain, Psychopharmacology, 191, 3, 2007. Crossref

  17. Mocci Giuseppe, Jiménez-Sánchez Laura, Adell Albert, Cortés Roser, Artigas Francesc, Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action, Neuropharmacology, 79, 2014. Crossref

  18. Burton Cynthia Z., Vella Lea, Harvey Philip D., Patterson Thomas L., Heaton Robert K., Twamley Elizabeth W., Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia, Schizophrenia Research, 146, 1-3, 2013. Crossref

  19. Mazhari Shahrzad, Parvaresh Nooshin, Eslami Shahrbabaki Mahin, Sadeghi Mohammad M., Nakhaee Nouzar, Keefe Richard S. E., Validation of the Persian version of the Brief Assessment of Cognition in Schizophrenia in patients with schizophrenia and healthy controls, Psychiatry and Clinical Neurosciences, 68, 2, 2014. Crossref

  20. Glen W. Bailey, Horowitz Bryant, Carlson Gregory C., Cannon Tyrone D., Talbot Konrad, Jentsch J. David, Lavin Antonieta, Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning, Hippocampus, 24, 2, 2014. Crossref

  21. Koh Hae-Young, Phospholipase C-β1 and schizophrenia-related behaviors, Advances in Biological Regulation, 53, 3, 2013. Crossref

  22. Ochoa Enrique L. M., Lasalde-Dominicci Jose, Cognitive Deficits in Schizophrenia: Focus on Neuronal Nicotinic Acetylcholine Receptors and Smoking, Cellular and Molecular Neurobiology, 27, 5, 2007. Crossref

  23. Ben Abdallah Nada M.-B., Fuss Johannes, Trusel Massimo, Galsworthy Michael J., Bobsin Kristin, Colacicco Giovanni, Deacon Robert M.J., Riva Marco A., Kellendonk Christoph, Sprengel Rolf, Lipp Hans-Peter, Gass Peter, The puzzle box as a simple and efficient behavioral test for exploring impairments of general cognition and executive functions in mouse models of schizophrenia, Experimental Neurology, 227, 1, 2011. Crossref

  24. De Herdt Amber, Wampers Martien, Vancampfort Davy, De Hert Marc, Vanhees Luc, Demunter Hella, Van Bouwel Ludwina, Brunner Emanuel, Probst Michel, Neurocognition in clinical high risk young adults who did or did not convert to a first schizophrenic psychosis: A meta-analysis, Schizophrenia Research, 149, 1-3, 2013. Crossref

  25. Boyer Laurent, Richieri Raphaëlle, Guedj Eric, Faget-Agius Catherine, Loundou Anderson, Llorca Pierre-Michel, Auquier Pascal, Lançon Christophe, Validation of a functional remission threshold for the Functional Remission of General Schizophrenia (FROGS) scale, Comprehensive Psychiatry, 54, 7, 2013. Crossref

  26. Glausier J.R., Lewis D.A., Dendritic spine pathology in schizophrenia, Neuroscience, 251, 2013. Crossref

  27. Norlelawati A. Talib, Kartini Abdullah, Norsidah Kuzaifah, Ramli Musa, Wan Azizi Wan Sulaiman, Tariq Abdul Razak, Relationship of psychological symptoms, antipsychotics and social data with psychosocial function in schizophrenia patients in Malaysia, Asia-Pacific Psychiatry, 7, 1, 2015. Crossref

  28. Lewis David A, Gonzalez-Burgos Guillermo, Pathophysiologically based treatment interventions in schizophrenia, Nature Medicine, 12, 9, 2006. Crossref

  29. Baumstarck Karine, Boyer Laurent, Boucekine Mohamed, Aghababian Valérie, Parola Nathalie, Lançon Christophe, Auquier Pascal, Self-reported quality of life measure is reliable and valid in adult patients suffering from schizophrenia with executive impairment, Schizophrenia Research, 147, 1, 2013. Crossref

  30. Restek-Petrović Branka, Bogović Anamarija, Mihanović Mate, Grah Majda, Mayer Nina, Ivezić Ena, Changes in aspects of cognitive functioning in young patients with schizophrenia during group psychodynamic psychotherapy: A preliminary study, Nordic Journal of Psychiatry, 68, 5, 2014. Crossref

  31. Butts K.A., Floresco S.B., Phillips A.G., Acute stress impairs set-shifting but not reversal learning, Behavioural Brain Research, 252, 2013. Crossref

  32. Wadehra Sunali, Pruitt Patrick, Murphy Eric R., Diwadkar Vaibhav A., Network dysfunction during associative learning in schizophrenia: Increased activation, but decreased connectivity: An fMRI study, Schizophrenia Research, 148, 1-3, 2013. Crossref

  33. Zhang Chen, Cai Jun, Zhang Jiangtao, Li Zezhi, Guo Zhongwei, Zhang Xu, Lu Weihong, Zhang Yi, Yuan Aihua, Yu Shunying, Fang Yiru, Genetic modulation of working memory deficits by ankyrin 3 gene in schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 50, 2014. Crossref

  34. Huerta-Ramos Elena, Iniesta Raquel, Ochoa Susana, Cobo Jesús, Miquel Eva, Roca Mercedes, Serrano-Blanco Antoni, Teba Fernando, Usall Judith, Effects of raloxifene on cognition in postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial, European Neuropsychopharmacology, 24, 2, 2014. Crossref

  35. Lee Young-A, Goto Yukiori, Reconsideration of animal models of schizophrenia and other psychiatric disorders with evolutionary perspective, Medical Hypotheses, 81, 6, 2013. Crossref

  36. Bonilha Leonardo, Molnar Chris, Horner Michael D., Anderson Berry, Forster Lauren, George Mark S., Nahas Ziad, Neurocognitive deficits and prefrontal cortical atrophy in patients with schizophrenia, Schizophrenia Research, 101, 1-3, 2008. Crossref

  37. Brébion Gildas, Bressan Rodrigo A., Ohlsen Ruth I., David Anthony S., A model of memory impairment in schizophrenia: Cognitive and clinical factors associated with memory efficiency and memory errors, Schizophrenia Research, 151, 1-3, 2013. Crossref

  38. Genderson Margo R., Dickinson Dwight, Diaz-Asper Catherine M., Egan Michael F., Weinberger Daniel R., Goldberg Terry E., Factor analysis of neurocognitive tests in a large sample of schizophrenic probands, their siblings, and healthy controls, Schizophrenia Research, 94, 1-3, 2007. Crossref

  39. Koh H.-Y., Kim D., Lee J., Lee S., Shin H.-S., Deficits in social behavior and sensorimotor gating in mice lacking phospholipase C?1, Genes, Brain and Behavior, 2007. Crossref

  40. Godsil Bill P., Kiss Janos P., Spedding Michael, Jay Thérèse M., The hippocampal–prefrontal pathway: The weak link in psychiatric disorders?, European Neuropsychopharmacology, 23, 10, 2013. Crossref

  41. Moran Lauren V., Tagamets Malle A., Sampath Hemalatha, O’Donnell Alan, Stein Elliot A., Kochunov Peter, Hong L. Elliot, Disruption of Anterior Insula Modulation of Large-Scale Brain Networks in Schizophrenia, Biological Psychiatry, 74, 6, 2013. Crossref

  42. Coy Abbie L., Hutton Samuel B., The influence of hallucination proneness and social threat on time perception, Cognitive Neuropsychiatry, 18, 6, 2013. Crossref

  43. Takahashi Shun, Ukai Satoshi, Kose Asami, Hashimoto Tadahiro, Iwatani Jun, Okumura Masatoshi, Tsuji Tomikimi, Shinosaki Kazuhiro, Reduction of cortical GABAergic inhibition correlates with working memory impairment in recent onset schizophrenia, Schizophrenia Research, 146, 1-3, 2013. Crossref

  44. Dorph-Petersen Karl-Anton, Pierri Joseph N., Sun Zhuoxin, Sampson Allan R., Lewis David A., Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: Volume, neuron number, and cell types, The Journal of Comparative Neurology, 472, 4, 2004. Crossref

  45. F. Egan Michael, Zhao Xin, Gottwald Regina, Harper-Mozley Lyn, Zhang Ying, Snavely Duane, Lines Christopher, Michelson David, Randomized crossover study of the histamine H3 inverse agonist MK-0249 for the treatment of cognitive impairment in patients with schizophrenia, Schizophrenia Research, 146, 1-3, 2013. Crossref

  46. Krueger Dilja D., Howell Jessica L., Hebert Britni F., Olausson Peter, Taylor Jane R., Nairn Angus C., Assessment of cognitive function in the heterozygous reeler mouse, Psychopharmacology, 189, 1, 2006. Crossref

  47. Celada Pau, Puig M. Victoria, Díaz-Mataix Llorenç, Artigas Francesc, The Hallucinogen DOI Reduces Low-Frequency Oscillations in Rat Prefrontal Cortex: Reversal by Antipsychotic Drugs, Biological Psychiatry, 64, 5, 2008. Crossref

  48. Blot Kevin, Bai Jing, Otani Satoru, The effect of non-competitive NMDA receptor antagonist MK-801 on neuronal activity in rodent prefrontal cortex: an animal model for cognitive symptoms of schizophrenia, Journal of Physiology-Paris, 107, 6, 2013. Crossref

  49. Lewis David A., Hashimoto Takanori, Deciphering the Disease Process of Schizophrenia: The Contribution of Cortical Gaba Neurons, in Integrating the Neurobiology of Schizophrenia, 78, 2007. Crossref

  50. Niitsu Tomihisa, Shirayama Yukihiko, Matsuzawa Daisuke, Hasegawa Tadashi, Kanahara Nobuhisa, Hashimoto Tasuku, Shiraishi Tetsuya, Shiina Akihiro, Fukami Goro, Fujisaki Mihisa, Watanabe Hiroyuki, Nakazato Michiko, Asano Makoto, Kimura Sho, Hashimoto Kenji, Iyo Masaomi, Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35, 8, 2011. Crossref

  51. Brown Russell W., Thompson Kimberly N., Click Ivy A., Best Razaria A. C., Thacker Stephanie K., Perna Marla K., The effects of eticlopride on Morris water task performance in male and female rats neonatally treated with quinpirole, Psychopharmacology, 180, 2, 2005. Crossref

  52. Vilardaga Roger, Hayes Steven C., Atkins David C., Bresee Christie, Kambiz Alaei, Comparing experiential acceptance and cognitive reappraisal as predictors of functional outcome in individuals with serious mental illness, Behaviour Research and Therapy, 51, 8, 2013. Crossref

  53. Bowins Brad, A cognitive regulatory control model of schizophrenia, Brain Research Bulletin, 85, 1-2, 2011. Crossref

  54. Newton Samuel S, Duman Ronald S, Neurogenic Actions of Atypical Antipsychotic Drugs and Therapeutic Implications, CNS Drugs, 21, 9, 2007. Crossref

  55. Fernandes C., Hoyle E., Dempster E., Schalkwyk L. C., Collier D. A., Performance deficit of α7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory, Genes, Brain and Behavior, 5, 6, 2006. Crossref

  56. Bossong Matthijs G., Jansma J. Martijn, Bhattacharyya Sagnik, Ramsey Nick F., Role of the endocannabinoid system in brain functions relevant for schizophrenia: An overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC), Progress in Neuro-Psychopharmacology and Biological Psychiatry, 52, 2014. Crossref

  57. Lei Gang, Anastasio Noelle C., Fu Yu, Neugebauer Volker, Johnson Kenneth M., Activation of dopamine D1 receptors blocks phencyclidine-induced neurotoxicity by enhancingN-methyl-D-aspartate receptor-mediated synaptic strength, Journal of Neurochemistry, 109, 4, 2009. Crossref

  58. Chang Wing Chung, Man Tang Jennifer Yee, Ming Hui Christy Lai, Wa Chan Sherry Kit, Ming Lee Edwin Ho, Hai Chen Eric Yu, Clinical and cognitive predictors of vocational outcome in first-episode schizophrenia: A prospective 3 year follow-up study, Psychiatry Research, 220, 3, 2014. Crossref

  59. Nikiforuk Agnieszka, Popik Piotr, The effects of acute and repeated administration of ketamine on attentional performance in the five-choice serial reaction time task in rats, European Neuropsychopharmacology, 24, 8, 2014. Crossref

  60. Mazhari Shahrzad, Moghadas Tabrizi Yousef, Abnormalities of mental rotation of hands associated with speed of information processing and executive function in chronic schizophrenic patients, Psychiatry and Clinical Neurosciences, 68, 6, 2014. Crossref

  61. Dang Jin, Zhang Jiangtao, Guo Zhongwei, Lu Weihong, Cai Jun, Shi Zhongying, Zhang Chen, A Pilot Study of iPad-Assisted Cognitive Training for Schizophrenia, Archives of Psychiatric Nursing, 28, 3, 2014. Crossref

  62. Burban Aude, Sadakhom Chit, Dumoulin Dominique, Rose Christiane, Le Pen Gwenaëlle, Frances Henriette, Arrang Jean-Michel, Modulation of prepulse inhibition and stereotypies in rodents: no evidence for antipsychotic-like properties of histamine H3-receptor inverse agonists, Psychopharmacology, 210, 4, 2010. Crossref

  63. Long Leonora E., Chesworth Rose, Huang Xu-Feng, McGregor Iain S., Arnold Jonathon C., Karl Tim, A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice, The International Journal of Neuropsychopharmacology, 13, 07, 2010. Crossref

  64. Rosenstein Mark, Diaz-Asper Catherine, Foltz Peter W., Elvevåg Brita, A computational language approach to modeling prose recall in schizophrenia, Cortex, 55, 2014. Crossref

  65. McLean Samantha L., Woolley Marie L., Thomas Dave, Neill Joanna C., Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat, Psychopharmacology, 206, 3, 2009. Crossref

  66. Curley Allison A., Lewis David A., Cortical basket cell dysfunction in schizophrenia, The Journal of Physiology, 590, 4, 2012. Crossref

  67. Hermens Daniel F., Redoblado Hodge M. Antoinette, Naismith Sharon L., Kaur Manreena, Scott Elizabeth, Hickie Ian B., Neuropsychological Clustering Highlights Cognitive Differences In Young People Presenting With Depressive Symptoms, Journal of the International Neuropsychological Society, 17, 2, 2011. Crossref

  68. Silver Henry, Bilker Warren, Goodman Craig, Impaired recognition of happy, sad and neutral expressions in schizophrenia is emotion, but not valence, specific and context dependent, Psychiatry Research, 169, 2, 2009. Crossref

  69. Seter Colette, Giovannetti Tania, Kessler Rachel K., Worth Shataya, Everyday action planning in schizophrenia, Neuropsychological Rehabilitation, 21, 2, 2011. Crossref

  70. Yang Yuan-Jian, Li Yan-Kun, Wang Wei, Wan Jian-Guo, Yu Bin, Wang Mei-Zhen, Hu Bin, Small-molecule TrkB agonist 7,8-dihydroxyflavone reverses cognitive and synaptic plasticity deficits in a rat model of schizophrenia, Pharmacology Biochemistry and Behavior, 122, 2014. Crossref

  71. Rial Daniel, Lara Diogo R., Cunha Rodrigo A., The Adenosine Neuromodulation System in Schizophrenia, in Adenosine Receptors in Neurology and Psychiatry, 119, 2014. Crossref

  72. Owens S. F., Picchioni M. M., Rijsdijk F. V., Stahl D., Vassos E., Rodger A. K., Collier D. A., Murray R. M., Toulopoulou T., Genetic overlap between episodic memory deficits and schizophrenia: results from The Maudsley Twin Study, Psychological Medicine, 41, 3, 2011. Crossref

  73. Mercedes Perez-Rodriguez M., Mahon Katie, Russo Manuela, Ungar Allison K., Burdick Katherine E., Oxytocin and social cognition in affective and psychotic disorders, European Neuropsychopharmacology, 25, 2, 2015. Crossref

  74. Littrell Jill Leslie, Will the Treatment Protocols for Schizophrenia be Changing Soon?, Social Work in Mental Health, 12, 4, 2014. Crossref

  75. Long Leonora E., Chesworth Rose, Arnold Jonathon C., Karl Tim, A follow-up study: acute behavioural effects of Δ9-THC in female heterozygous Neuregulin 1 transmembrane domain mutant mice, Psychopharmacology, 211, 3, 2010. Crossref

  76. Guo Xiaofeng, Li Jun, Wang Juan, Fan Xiaoduo, Hu Maorong, Shen Yidong, Chen Huafu, Zhao Jingping, Hippocampal and orbital inferior frontal gray matter volume abnormalities and cognitive deficit in treatment-naive, first-episode patients with schizophrenia, Schizophrenia Research, 152, 2-3, 2014. Crossref

  77. Scholes K. E., Martin-Iverson M. T., Cannabis use and neuropsychological performance in healthy individuals and patients with schizophrenia, Psychological Medicine, 40, 10, 2010. Crossref

  78. Sendt Kyra-Verena, Tracy Derek Kenneth, Bhattacharyya Sagnik, A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders, Psychiatry Research, 225, 1-2, 2015. Crossref

  79. Lewis David A., The chandelier neuron in schizophrenia, Developmental Neurobiology, 71, 1, 2011. Crossref

  80. Waford Rachel N., Lewine Richard, Is perseveration uniquely characteristic of schizophrenia?, Schizophrenia Research, 118, 1-3, 2010. Crossref

  81. Rodriguez-Jimenez R., Bagney A., Garcia-Navarro C., Aparicio A.I., Lopez-Anton R., Moreno-Ortega M., Jimenez-Arriero M.A., Santos J.L., Lobo A., Kern R.S., Green M.F., Nuechterlein K.H., Palomo T., The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in Spain, Schizophrenia Research, 134, 2-3, 2012. Crossref

  82. Karayiorgou Maria, Simon Tony J., Gogos Joseph A., 22q11.2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia, Nature Reviews Neuroscience, 11, 6, 2010. Crossref

  83. Wędzony Krzysztof, Chocyk Agnieszka, Cannabinoid CB1 receptors in rat medial prefrontal cortex are colocalized with calbindin but not parvalbumin- and calretinin-positive GABA-ergic neurons, Pharmacological Reports, 61, 6, 2009. Crossref

  84. Amitai Nurith, Markou Athina, Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration, Psychopharmacology, 202, 1-3, 2009. Crossref

  85. Pinheiro Andrea Poyastro, Keefe Richard S.E., Skelly Tara, Olarte Megan, Leviel Keren, Lange Leslie A., Lange Ethan M., Stroup T. Scott, Lieberman Jeffrey, Sullivan Patrick F., AKT1 and Neurocognition in Schizophrenia, Australian & New Zealand Journal of Psychiatry, 41, 2, 2007. Crossref

  86. Rabinovich Mikhail I., Sokolov Yury, Kozma Robert, Robust sequential working memory recall in heterogeneous cognitive networks, Frontiers in Systems Neuroscience, 8, 2014. Crossref

  87. Lewis David A., Hashimoto Takanori, Morris Harvey M., Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia, Neurotoxicity Research, 14, 2-3, 2008. Crossref

  88. Nekovarova Tereza, Fajnerova Iveta, Horacek Jiri, Spaniel Filip, Bridging disparate symptoms of schizophrenia: a triple network dysfunction theory, Frontiers in Behavioral Neuroscience, 8, 2014. Crossref

  89. Maggouritsa Georgia, Kokaridas Dimitrios, Theodorakis Ioannis, Patsiaouras Asterios, Mouzas Odysseas, Dimitrakopoulos Stefanos, Diggelidis Nikolaos, The effect of a physical activity programme on improving mood profile of patients with schizophrenia, International Journal of Sport and Exercise Psychology, 12, 3, 2014. Crossref

  90. Docherty Anna R., Hagler Donald J., Panizzon Matthew S., Neale Michael C., Eyler Lisa T., Fennema-Notestine Christine, Franz Carol E., Jak Amy, Lyons Michael J., Rinker Daniel A., Thompson Wesley K., Tsuang Ming T., Dale Anders M., Kremen William S., Does degree of gyrification underlie the phenotypic and genetic associations between cortical surface area and cognitive ability?, NeuroImage, 106, 2015. Crossref

  91. Peleg-Raibstein Daria, Yee Benjamin K., Feldon Joram, Hauser Jonas, The amphetamine sensitization model of schizophrenia: relevance beyond psychotic symptoms?, Psychopharmacology, 206, 4, 2009. Crossref

  92. Chen Chi-Ming A., Stanford Arielle D., Mao Xiangling, Abi-Dargham Anissa, Shungu Dikoma C., Lisanby Sarah H., Schroeder Charles E., Kegeles Lawrence S., GABA level, gamma oscillation, and working memory performance in schizophrenia, NeuroImage: Clinical, 4, 2014. Crossref

  93. Elsworth John D, Jentsch J David, Morrow Bret A, Redmond D Eugene, Roth Robert H, Clozapine Normalizes Prefrontal Cortex Dopamine Transmission in Monkeys Subchronically Exposed to Phencyclidine, Neuropsychopharmacology, 33, 3, 2008. Crossref

  94. Vaskinn Anja, Ueland Torill, Melle Ingrid, Agartz Ingrid, Andreassen Ole A., Sundet Kjetil, Neurocognitive Decrements are Present in Intellectually Superior Schizophrenia, Frontiers in Psychiatry, 5, 2014. Crossref

  95. Artigas F., The prefrontal cortex: a target for antipsychotic drugs, Acta Psychiatrica Scandinavica, 121, 1, 2010. Crossref

  96. Gruber Oliver, Chadha Santuccione Antonella, Aach Helmut, Magnetic Resonance Imaging in Studying Schizophrenia, Negative Symptoms, and the Glutamate System, Frontiers in Psychiatry, 5, 2014. Crossref

  97. Leung Chung-Ming, Stone William S., Lee Edwin Ho-Ming, Seidman Larry J., Chen Eric Yu-Hai, Impaired facilitation of self-control cognition by glucose in patients with schizophrenia: A randomized controlled study, Schizophrenia Research, 156, 1, 2014. Crossref

  98. González-Hernández J.A., Pita-Alcorta C., Padrón A., Finalé A., Galán L., Martínez E., Díaz-Comas L., Samper-González J.A., Lencer R., Marot M., Basic visual dysfunction allows classification of patients with schizophrenia with exceptional accuracy, Schizophrenia Research, 159, 1, 2014. Crossref

  99. VASKINN ANJA, SUNDET KJETIL, FRIIS SVEIN, SIMONSEN CARMEN, BIRKENAES ASTRID B., JÓNSDÓTTIR HALLDORA, RINGEN PETTER ANDREAS, ANDREASSEN OLE A., Emotion perception and learning potential: Mediators between neurocognition and social problem-solving in schizophrenia?, Journal of the International Neuropsychological Society, 14, 02, 2008. Crossref

  100. Eisenberg Daniel Paul, Berman Karen Faith, Executive Function, Neural Circuitry, and Genetic Mechanisms in Schizophrenia, Neuropsychopharmacology, 35, 1, 2010. Crossref

  101. LEWIS DAVID A., CRUZ DIANNE, EGGAN STEPHEN, ERICKSON SUSAN, Postnatal Development of Prefrontal Inhibitory Circuits and the Pathophysiology of Cognitive Dysfunction in Schizophrenia, Annals of the New York Academy of Sciences, 1021, 1, 2004. Crossref

  102. Song Xueqin, Quan Meina, Lv Luxian, Li Xue, Pang Lijuan, Kennedy David, Hodge Steven, Harrington Amy, Ziedonis Douglas, Fan Xiaoduo, Decreased cortical thickness in drug naïve first episode schizophrenia: In relation to serum levels of BDNF, Journal of Psychiatric Research, 60, 2015. Crossref

  103. Huddy V. C., Aron A. R., Harrison M., Barnes T. R. E., Robbins T. W., Joyce E. M., Impaired conscious and preserved unconscious inhibitory processing in recent onset schizophrenia, Psychological Medicine, 39, 6, 2009. Crossref

  104. Fajnerová Iveta, Rodriguez Mabel, Levčík David, Konrádová Lucie, Mikoláš Pavol, Brom Cyril, Stuchlík Aleš, Vlček Kamil, Horáček Jiří, A virtual reality task based on animal research – spatial learning and memory in patients after the first episode of schizophrenia, Frontiers in Behavioral Neuroscience, 8, 2014. Crossref

  105. Bortolozzi Analía, Masana Mercè, Díaz-Mataix Llorenç, Cortés Roser, Scorza María Cecilia, Gingrich Jay A., Toth Miklos, Artigas Francesc, Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT1A receptors but not 5-HT2A receptors, The International Journal of Neuropsychopharmacology, 13, 10, 2010. Crossref

  106. Badcock Johanna C., Dragović Milan, Waters Flavie A.V., Jablensky Assen, Dimensions of intelligence in schizophrenia: evidence from patients with preserved, deteriorated and compromised intellect, Journal of Psychiatric Research, 39, 1, 2005. Crossref

  107. Li Ji-Tao, Su Yun-Ai, Guo Chun-Mei, Feng Yu, Yang Yang, Huang Run-Hu, Si Tian-Mei, Persisting cognitive deficits induced by low-dose, subchronic treatment with MK-801 in adolescent rats, European Journal of Pharmacology, 652, 1-3, 2011. Crossref

  108. Wölwer Wolfgang, Brinkmeyer Jürgen, Riesbeck Mathias, Freimüller Lena, Klimke Ansgar, Wagner Michael, Möller Hans-Jürgen, Klingberg Stefan, Gaebel Wolfgang, Neuropsychological impairments predict the clinical course in schizophrenia, European Archives of Psychiatry and Clinical Neuroscience, 258, S5, 2008. Crossref

  109. Zhang Bao Hua, Han Mei, Zhang Xiang Yang, Hui Li, Jiang Shu Rong, Yang Fu De, Tan Yun Long, Wang Zhi Ren, Li Juan, Huang Xu Feng, Gender differences in cognitive deficits in schizophrenia with and without diabetes, Comprehensive Psychiatry, 63, 2015. Crossref

  110. Cho Youngah, Ryu Seunghyong, Huh Iksoo, Cho Eun Young, Oh Hyeji, Lee Yu-Sang, Lee Woo Kyeong, Park Taesung, Kwon Jun Soo, Hong Kyung Sue, Effects of genetic variations in NRG1 on cognitive domains in patients with schizophrenia and healthy individuals, Psychiatric Genetics, 25, 4, 2015. Crossref

  111. Boyer Patrice, Phillips Jennifer L., Rousseau François L., Ilivitsky Susan, Hippocampal abnormalities and memory deficits: New evidence of a strong pathophysiological link in schizophrenia, Brain Research Reviews, 54, 1, 2007. Crossref

  112. Barnes S.A., Young J.W., Bate S.T., Neill J.C., Dopamine D1 receptor activation improves PCP-induced performance disruption in the 5C-CPT by reducing inappropriate responding, Behavioural Brain Research, 300, 2016. Crossref

  113. Verduzco-Flores Sergio, Ermentrout Bard, Bodner Mark, Modeling neuropathologies as disruption of normal sequence generation in working memory networks, Neural Networks, 27, 2012. Crossref

  114. Marquis J.-P., Goulet S., Doré F.Y., Neonatal lesions of the ventral hippocampus in rats lead to prefrontal cognitive deficits at two maturational stages, Neuroscience, 140, 3, 2006. Crossref

  115. Hanlon Robert E., Coda Joseph J., Cobia Derin, Rubin Leah H., Psychotic Domestic Murder: Neuropsychological Differences Between Homicidal and Nonhomicidal Schizophrenic Men, Journal of Family Violence, 27, 2, 2012. Crossref

  116. Cameron Allison M, Oram Joanne, Geffen Gina M, Kavanagh David J, McGrath John J, Geffen Laurie B, Working memory correlates of three symptom clusters in schizophrenia, Psychiatry Research, 110, 1, 2002. Crossref

  117. Chapman Justin J., Fraser Sarah J., Brown Wendy J., Burton Nicola W., The feasibility and acceptability of questionnaires and accelerometry for measuring physical activity and sedentary behaviour in adults with mental illness, Journal of Mental Health, 24, 5, 2015. Crossref

  118. Huang Ching-Hsun, Pei Ju-Chun, Luo Da-Zhong, Chen Ching, Chen Yi-Wen, Lai Wen-Sung, Investigation of gene effects and epistatic interactions between Akt1 and neuregulin 1 in the regulation of behavioral phenotypes and social functions in genetic mouse models of schizophrenia, Frontiers in Behavioral Neuroscience, 8, 2015. Crossref

  119. Karayiorgou Maria, Gogos Joseph A., The molecular genetics of the 22q11-associated schizophrenia, Molecular Brain Research, 132, 2, 2004. Crossref

  120. Siu Cynthia O., Harvey Philip D., Agid Ofer, Waye Mary, Brambilla Carla, Choi Wing-Kit, Remington Gary, Insight and subjective measures of quality of life in chronic schizophrenia, Schizophrenia Research: Cognition, 2, 3, 2015. Crossref

  121. Sandu Anca-Larisa, Rasmussen Inge-Andre, Lundervold Arvid, Kreuder Frank, Neckelmann Gesche, Hugdahl Kenneth, Specht Karsten, Fractal dimension analysis of MR images reveals grey matter structure irregularities in schizophrenia, Computerized Medical Imaging and Graphics, 32, 2, 2008. Crossref

  122. Bossong Matthijs G., Niesink Raymond J.M., Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia, Progress in Neurobiology, 92, 3, 2010. Crossref

  123. Thakkar Katharine N., Schall Jeffrey D., Logan Gordon D., Park Sohee, Response inhibition and response monitoring in a saccadic double-step task in schizophrenia, Brain and Cognition, 95, 2015. Crossref

  124. Muraki Kazue, Tanigaki Kenji, Neuronal migration abnormalities and its possible implications for schizophrenia, Frontiers in Neuroscience, 9, 2015. Crossref

  125. Maldonado-Avilés Jaime G., Wu Qiang, Sampson Allan R., Lewis David A., Somal Size of Immunolabeled Pyramidal Cells in the Prefrontal Cortex of Subjects with Schizophrenia, Biological Psychiatry, 60, 3, 2006. Crossref

  126. Parolaro Daniela, Realini Natalia, Vigano Daniela, Guidali Cinzia, Rubino Tiziana, The endocannabinoid system and psychiatric disorders, Experimental Neurology, 224, 1, 2010. Crossref

  127. Keshavan Matcheri S., Montrose Debra M., Miewald Jean M., Jindal Ripu D., Sleep correlates of cognition in early course psychotic disorders, Schizophrenia Research, 131, 1-3, 2011. Crossref

  128. Pachou Ellie, Vourkas Michael, Simos Panagiotis, Smit Dirk, Stam Cornelis J., Tsirka Vasso, Micheloyannis Sifis, Working Memory in Schizophrenia: An EEG Study Using Power Spectrum and Coherence Analysis to Estimate Cortical Activation and Network Behavior, Brain Topography, 21, 2, 2008. Crossref

  129. Shirayama Yukihiko, Takahashi Michio, Suzuki Masatoshi, Tsuruoka Yoshiaki, Sato Koichi, Effects of Add-on Ramelteon on Cognitive Impairment in Patients with Schizophrenia: An Open-label Pilot Trial, Clinical Psychopharmacology and Neuroscience, 12, 3, 2014. Crossref

  130. Seibt Kelly Juliana, da Luz Oliveira Renata, Rico Eduardo Pacheco, Dias Renato Dutra, Bogo Mauricio Reis, Bonan Carla Denise, Typical and atypical antipsychotics alter acetylcholinesterase activity and ache expression in zebrafish (Danio rerio) brain, Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 150, 1, 2009. Crossref

  131. Impey Danielle, El-Marj Nicole, Parks Andrea, Choueiry Joelle, Fisher Derek, Knott Verner J., Mismatch negativity in tobacco-naïve cannabis users and its alteration with acute nicotine administration, Pharmacology Biochemistry and Behavior, 136, 2015. Crossref

  132. Porteous David J., Thomson Pippa, Brandon Nicholas J., Millar J. Kirsty, The Genetics and Biology of Disc1—An Emerging Role in Psychosis and Cognition, Biological Psychiatry, 60, 2, 2006. Crossref

  133. Yeragani Vikram Kumar, Cashmere David, Miewald Jean, Tancer Manuel, Keshavan Matcheri S., Decreased coherence in higher frequency ranges (beta and gamma) between central and frontal EEG in patients with schizophrenia: A preliminary report, Psychiatry Research, 141, 1, 2006. Crossref

  134. Hirata Yuko, Souza Renan P., Lieberman Jeffrey A., Meltzer Herbert Y., Kennedy James L., Lack of association between HTR4 gene polymorphisms and schizophrenia in case–control and family-based samples, Psychiatry Research, 175, 1-2, 2010. Crossref

  135. Waddington John L., Corvin Aiden P., Donohoe Gary, O'Tuathaigh Colm M.P., Mitchell Kevin J., Gill Michael, Functional Genomics and Schizophrenia: Endophenotypes and Mutant Models, Psychiatric Clinics of North America, 30, 3, 2007. Crossref

  136. Lencz Todd, Smith Christopher W., McLaughlin Danielle, Auther Andrea, Nakayama Emilie, Hovey Lauren, Cornblatt Barbara A., Generalized and Specific Neurocognitive Deficits in Prodromal Schizophrenia, Biological Psychiatry, 59, 9, 2006. Crossref

  137. Torrey E. Fuller, Yolken Robert H., Toxoplasma gondiiand Schizophrenia, Emerging Infectious Diseases, 9, 11, 2003. Crossref

  138. Marín Oscar, Interneuron dysfunction in psychiatric disorders, Nature Reviews Neuroscience, 13, 2, 2012. Crossref

  139. Arguello P. Alexander, Gogos Joseph A., Modeling Madness in Mice: One Piece at a Time, Neuron, 52, 1, 2006. Crossref

  140. Kos Mark Z., Carless Melanie A., Peralta Juan, Blackburn August, Almeida Marcio, Roalf David, Pogue-Geile Michael F., Prasad Konasale, Gur Ruben C., Nimgaonkar Vishwajit, Curran Joanne E., Duggirala Ravi, Glahn David C., Blangero John, Gur Raquel E., Almasy Laura, Exome Sequence Data From Multigenerational Families Implicate AMPA Receptor Trafficking in Neurocognitive Impairment and Schizophrenia Risk, Schizophrenia Bulletin, 42, 2, 2016. Crossref

  141. Allott Kelly, Brewer Warrick, Mcgorry Patrick D, Proffitt Tina‐marie, Referrers' Perceived Utility and Outcomes of Clinical Neuropsychological Assessment in an Adolescent and Young Adult Public Mental Health Service, Australian Psychologist, 46, 1, 2011. Crossref

  142. Becker Axel, Eyles Darryl W., McGrath John J., Grecksch Gisela, Transient prenatal vitamin D deficiency is associated with subtle alterations in learning and memory functions in adult rats, Behavioural Brain Research, 161, 2, 2005. Crossref

  143. Sanderson Thomas M., Cotel Marie-Caroline, O’Neill Michael J., Tricklebank Mark D., Collingridge Graham L., Sher Emanuele, Alterations in hippocampal excitability, synaptic transmission and synaptic plasticity in a neurodevelopmental model of schizophrenia, Neuropharmacology, 62, 3, 2012. Crossref

  144. Holcomb Henry H., Rowland Laura M., Tagamets Malle A., Cognitive dysfunction in schizophrenia: glutamatergic hypoactivity and dopaminergic failure, Drug Discovery Today: Disease Mechanisms, 1, 4, 2004. Crossref

  145. Blundell Jacqueline, Hoang Chau V., Potts Bryan, Gold Stephen J., Powell Craig M., Motor coordination deficits in mice lacking RGS9, Brain Research, 1190, 2008. Crossref

  146. Lacerda Acioly L.T., Hardan Antonio Y., Yorbik Ozgur, Vemulapalli Madhuri, Prasad Konasale M., Keshavan Matcheri S., Morphology of the orbitofrontal cortex in first-episode schizophrenia: Relationship with negative symptomatology, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31, 2, 2007. Crossref

  147. Rössler Wulf, Ajdacic-Gross Vladeta, Müller Mario, Rodgers Stephanie, Kawohl Wolfram, Haker Helene, Hengartner Michael P., Association between processing speed and subclinical psychotic symptoms in the general population: Focusing on sex differences, Schizophrenia Research, 166, 1-3, 2015. Crossref

  148. Peterson Jordan B, Smith Kathleen W, Carson Shelley, Openness and extraversion are associated with reduced latent inhibition: replication and commentary, Personality and Individual Differences, 33, 7, 2002. Crossref

  149. Lidow Michael S, Calcium signaling dysfunction in schizophrenia: a unifying approach, Brain Research Reviews, 43, 1, 2003. Crossref

  150. Arion Dominique, Horváth Szatmár, Lewis David A., Mirnics Károly, Infragranular gene expression disturbances in the prefrontal cortex in schizophrenia: Signature of altered neural development?, Neurobiology of Disease, 37, 3, 2010. Crossref

  151. Ortega-Alvaro Antonio, Gibert-Rahola Juan, Micó Juan A., Influence of chronic treatment with olanzapine, clozapine and scopolamine on performance of a learned 8-arm radial maze task in rats, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30, 1, 2006. Crossref

  152. Twamley Elizabeth W., Woods Steven Paul, Zurhellen Cynthia H., Vertinski Mary, Narvaez Jenille M., Mausbach Brent T., Patterson Thomas L., Jeste Dilip V., Neuropsychological substrates and everyday functioning implications of prospective memory impairment in schizophrenia, Schizophrenia Research, 106, 1, 2008. Crossref

  153. Watanabe Yoshinori, Urakami Takahiro, Hongo Seiji, Ohtsubo Tenpei, Frontal lobe function and social adjustment in patients with schizophrenia: near‐infrared spectroscopy, Human Psychopharmacology: Clinical and Experimental, 30, 1, 2015. Crossref

  154. Lo Wing-Sze, Harano Mutsuo, Gawlik Micha, Yu Zhiliang, Chen Jianhuan, Pun Frank W., Tong Ka-Lok, Zhao Cunyou, Ng Siu-Kin, Tsang Shui-Ying, Uchimura Naohisa, Stober Gerald, Xue Hong, GABRB2 Association with Schizophrenia: Commonalities and Differences Between Ethnic Groups and Clinical Subtypes, Biological Psychiatry, 61, 5, 2007. Crossref

  155. Stratta Paolo, Arduini Luca, Daneluzzo Enrico, Rinaldi Osvaldo, di Genova Andrea, Rossi Alessandro, Relationship of good and poor Wisconsin Card Sorting Test performance to illness duration in schizophrenia: a cross-sectional analysis, Psychiatry Research, 121, 3, 2004. Crossref

  156. Shiina Akihiro, Kanahara Nobuhisa, Sasaki Tsuyoshi, Oda Yasunori, Hashimoto Tasuku, Hasegawa Tadashi, Yoshida Taisuke, Iyo Masaomi, Hashimoto Kenji, An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia, Clinical Psychopharmacology and Neuroscience, 13, 1, 2015. Crossref

  157. Meyer Urs, Schwarz Markus J., Müller Norbert, Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond, Pharmacology & Therapeutics, 132, 1, 2011. Crossref

  158. Powell Craig M., Miyakawa Tsuyoshi, Schizophrenia-Relevant Behavioral Testing in Rodent Models: A Uniquely Human Disorder?, Biological Psychiatry, 59, 12, 2006. Crossref

  159. Vreeker Annabel, van Bergen Annet H., Kahn René S., Cognitive enhancing agents in schizophrenia and bipolar disorder, European Neuropsychopharmacology, 25, 7, 2015. Crossref

  160. Peuskens Joseph, Clinical effectiveness in adults with chronic schizophrenia, European Neuropsychopharmacology, 14, 2004. Crossref

  161. Keefe Richard S.E., Eesley Charles E., Poe Margaret P., Defining a cognitive function decrement in schizophrenia, Biological Psychiatry, 57, 6, 2005. Crossref

  162. Pritchett David, Wulff Katharina, Oliver Peter L., Bannerman David M., Davies Kay E., Harrison Paul J., Peirson Stuart N., Foster Russell G., Evaluating the links between schizophrenia and sleep and circadian rhythm disruption, Journal of Neural Transmission, 119, 10, 2012. Crossref

  163. Papaleo Francesco, Lipska Barbara K., Weinberger Daniel R., Mouse models of genetic effects on cognition: Relevance to schizophrenia, Neuropharmacology, 62, 3, 2012. Crossref

  164. Liu Yong, Chen Jindong, Song Tao, Hu Changping, Tang Yamei, Zhang Xianghui, Zhao Jingping, Contribution of K+–Cl− cotransporter 2 in MK-801-induced impairment of long term potentiation, Behavioural Brain Research, 201, 2, 2009. Crossref

  165. Eriksson Åsa, Hodgins Sheilagh, Tengström Anders, Verbal Intelligence and Criminal Offending Among Men With Schizophrenia, International Journal of Forensic Mental Health, 4, 2, 2005. Crossref

  166. Gunduz-Bruce Handan, Reinhart Robert M.G., Roach Brian J., Gueorguieva Ralitza, Oliver Stephen, D'Souza Deepak C., Ford Judith M., Krystal John H., Mathalon Daniel H., Glutamatergic Modulation of Auditory Information Processing in the Human Brain, Biological Psychiatry, 71, 11, 2012. Crossref

  167. Kim Seong-Wook, Cho Taesup, Lee Sukchan, Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia, Frontiers in Psychiatry, 6, 2015. Crossref

  168. Allott Kelly, Proffitt Tina-Marie, McGorry Patrick D., Pantelis Christos, Wood Stephen J., Cumner Marnie, Brewer Warrick J., Clinical Neuropsychology Within Adolescent and Young-Adult Psychiatry: Conceptualizing Theory and Practice, Applied Neuropsychology: Child, 2, 1, 2013. Crossref

  169. Gilmour Gary, Dix Sophie, Fellini Laetitia, Gastambide Francois, Plath Niels, Steckler Thomas, Talpos John, Tricklebank Mark, NMDA receptors, cognition and schizophrenia – Testing the validity of the NMDA receptor hypofunction hypothesis, Neuropharmacology, 62, 3, 2012. Crossref

  170. Selva Gabriel, Salazar José, Balanzá-Martínez Vicent, Martínez-Arán Anabel, Rubio Cristina, Daban Claire, Sánchez-Moreno José, Vieta Eduard, Tabarés-Seisdedos Rafael, Bipolar I patients with and without a history of psychotic symptoms: Do they differ in their cognitive functioning?, Journal of Psychiatric Research, 41, 3-4, 2007. Crossref

  171. Frings Christian, Schneider Katja Kerstin, Fox Elaine, The negative priming paradigm: An update and implications for selective attention, Psychonomic Bulletin & Review, 22, 6, 2015. Crossref

  172. Howland J.G., Cazakoff B.N., Zhang Y., Altered object-in-place recognition memory, prepulse inhibition, and locomotor activity in the offspring of rats exposed to a viral mimetic during pregnancy, Neuroscience, 201, 2012. Crossref

  173. Feldon Joram, Meyer Urs, 15 Prenatal infections and long-term mental outcome: Modeling schizophrenia-related dysfunctions using the prenatal Polyl:C model in mice, in Perinatal Programming, 2011. Crossref

  174. Smith Dylan M., Fisher Derek, Blier Pierre, Ilivitsky Vadim, Knott Verner, The separate and combined effects of monoamine oxidase A inhibition and nicotine on the mismatch negativity event related potential, Pharmacology Biochemistry and Behavior, 137, 2015. Crossref

  175. Burdick Katherine E., Gunawardane Nisali, Woodberry Kristen, Malhotra Anil K., The role of general intelligence as an intermediate phenotype for neuropsychiatric disorders, Cognitive Neuropsychiatry, 14, 4-5, 2009. Crossref

  176. Meyer Urs, Feldon Joram, Epidemiology-driven neurodevelopmental animal models of schizophrenia, Progress in Neurobiology, 90, 3, 2010. Crossref

  177. Aguilar-Valles Argel, Luheshi Giamal N., Alterations in cognitive function and behavioral response to amphetamine induced by prenatal inflammation are dependent on the stage of pregnancy, Psychoneuroendocrinology, 36, 5, 2011. Crossref

  178. Cole Michael W., Anticevic Alan, Repovs Grega, Barch Deanna, Variable Global Dysconnectivity and Individual Differences in Schizophrenia, Biological Psychiatry, 70, 1, 2011. Crossref

  179. Brown Russell W, Gass Justin T, Kostrzewa Richard M, Ontogenetic quinpirole treatments produce spatial memory deficits and enhance skilled reaching in adult rats, Pharmacology Biochemistry and Behavior, 72, 3, 2002. Crossref

  180. Simola Nicola, Bustamante Diego, Pinna Annalisa, Pontis Silvia, Morales Paola, Morelli Micaela, Herrera-Marschitz Mario, Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats, Experimental Brain Research, 185, 4, 2008. Crossref

  181. Cancho Ramon Ferrer i, When language breaks into pieces A conflict between communication through isolated signals and language, Biosystems, 84, 3, 2006. Crossref

  182. Nakao Akito, Miki Takafumi, Shoji Hirotaka, Nishi Miyuki, Takeshima Hiroshi, Miyakawa Tsuyoshi, Mori Yasuo, Comprehensive behavioral analysis of voltage-gated calcium channel beta-anchoring and -regulatory protein knockout mice, Frontiers in Behavioral Neuroscience, 9, 2015. Crossref

  183. Tabarés-Seisdedos Rafael, Balanzá-Martı́nez Vicente, Salazar-Fraile José, Selva-Vera Gabriel, Leal-Cercós Carmen, Gómez-Beneyto Manuel, Specific executive/attentional deficits in patients with schizophrenia or bipolar disorder who have a positive family history of psychosis, Journal of Psychiatric Research, 37, 6, 2003. Crossref

  184. Semenova Svetlana, Markou Athina, The effects of the mGluR5 antagonist MPEP and the mGluR2/3 antagonist LY341495 on rats' performance in the 5-choice serial reaction time task, Neuropharmacology, 52, 3, 2007. Crossref

  185. Lewis David A, González-Burgos Guillermo, Neuroplasticity of Neocortical Circuits in Schizophrenia, Neuropsychopharmacology, 33, 1, 2008. Crossref

  186. Amitai Nurith, Kuczenski Ronald, Behrens M. Margarita, Markou Athina, Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats, Neuropharmacology, 62, 3, 2012. Crossref

  187. Charych Erik I., Liu Feng, Moss Stephen J., Brandon Nicholas J., GABAA receptors and their associated proteins: Implications in the etiology and treatment of schizophrenia and related disorders, Neuropharmacology, 57, 5-6, 2009. Crossref

  188. Elvevåg Brita, Foltz Peter W., Rosenstein Mark, DeLisi Lynn E., An automated method to analyze language use in patients with schizophrenia and their first-degree relatives, Journal of Neurolinguistics, 23, 3, 2010. Crossref

  189. Hermens Daniel F., Ward Philip B., Hodge M. Antoinette Redoblado, Kaur Manreena, Naismith Sharon L., Hickie Ian B., Impaired MMN/P3a complex in first-episode psychosis: Cognitive and psychosocial associations, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34, 6, 2010. Crossref

  190. Cho Youngah, Ryu Seunghyong, Oh Hyeji, Oh Sohee, Park Taesung, Yoon Se Chang, Hong Kyung Sue, Correlation of Lifetime Symptom Dimensions with Cognitive Function and Other Clinical Characteristics in Schizophrenia Patients, Korean Journal of Schizophrenia Research, 17, 2, 2014. Crossref

  191. Martinelli Cristina, Shergill Sukhwinder S., Clarifying the role of pattern separation in schizophrenia: The role of recognition and visual discrimination deficits, Schizophrenia Research, 166, 1-3, 2015. Crossref

  192. Hall F. Scott, Markou Athina, Levin Edward D., Uhl George R., Mouse models for studying genetic influences on factors determining smoking cessation success in humans, Annals of the New York Academy of Sciences, 1248, 1, 2012. Crossref

  193. Wolitzky Rachel, Goudsmit Nora, Goetz Raymond R., Printz David, Gil Roberto, Harkavy-Friedman Jill, Malaspina Dolores, Etiological Heterogeneity and Intelligence Test Scores in Patients with Schizophrenia, Journal of Clinical and Experimental Neuropsychology, 28, 2, 2006. Crossref

  194. Sams Anette Graven, Larsen Krestian, Mikkelsen Gitte Kobberøe, Hentzer Morten, Christoffersen Claus Tornby, Jensen Klaus Gjervig, Frederiksen Kristen, Bang-Andersen Benny, Hit-to-lead investigation of a series of novel combined dopamine D2 and muscarinic M1 receptor ligands with putative antipsychotic and pro-cognitive potential, Bioorganic & Medicinal Chemistry Letters, 22, 15, 2012. Crossref

  195. Managó Francesca, Huang Huiping, Francesco Papaleo, Modeling Cognitive Impairment, in Modeling the Psychopathological Dimensions of Schizophrenia - From Molecules to Behavior, 23, 2016. Crossref

  196. Fejgin Kim, Pålsson Erik, Wass Caroline, Svensson Lennart, Klamer Daniel, Nitric Oxide Signaling in the Medial Prefrontal Cortex is Involved in the Biochemical and Behavioral Effects of Phencyclidine, Neuropsychopharmacology, 33, 8, 2008. Crossref

  197. Konopaske Glenn T., Dorph-Petersen Karl-Anton, Sweet Robert A., Pierri Joseph N., Zhang Wei, Sampson Allan R., Lewis David A., Effect of Chronic Antipsychotic Exposure on Astrocyte and Oligodendrocyte Numbers in Macaque Monkeys, Biological Psychiatry, 63, 8, 2008. Crossref

  198. Chen Guoliang, Zhang Lei, Ding Weiyan, Zhou Renlai, Xu Peng, Lu Shan, Sun Li, Jiang Zhongdong, Li Huiju, Li Yansong, Cui Hong, Event-related brain potential correlates of prospective memory in symptomatically remitted male patients with schizophrenia, Frontiers in Behavioral Neuroscience, 9, 2015. Crossref

  199. Lins Brittney R., Phillips Anthony G., Howland John G., Effects of D- and L-govadine on the disruption of touchscreen object-location paired associates learning in rats by acute MK-801 treatment, Psychopharmacology, 232, 23, 2015. Crossref

  200. Li Yingjie, Tong Shanbao, Liu Dan, Gai Yi, Wang Xiuyuan, Wang Jijun, Qiu Yihong, Zhu Yisheng, Abnormal EEG complexity in patients with schizophrenia and depression, Clinical Neurophysiology, 119, 6, 2008. Crossref

  201. Meyer Urs, Feldon Joram, Schedlowski Manfred, Yee Benjamin K., Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia, Neuroscience & Biobehavioral Reviews, 29, 6, 2005. Crossref

  202. Ozawa Kimiyoshi, Hashimoto Kenji, Kishimoto Takashi, Shimizu Eiji, Ishikura Hiroshi, Iyo Masaomi, Immune Activation During Pregnancy in Mice Leads to Dopaminergic Hyperfunction and Cognitive Impairment in the Offspring: A Neurodevelopmental Animal Model of Schizophrenia, Biological Psychiatry, 59, 6, 2006. Crossref

  203. Amitai Nurith, Markou Athina, Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats, European Journal of Pharmacology, 639, 1-3, 2010. Crossref

  204. Nyffeler M., Meyer U., Yee B.K., Feldon J., Knuesel I., Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: Implications for schizophrenia, Neuroscience, 143, 1, 2006. Crossref

  205. Bloomfield Claire, French Sarah J., Jones Declan N.C., Reavill Charlie, Southam Eric, Cilia Jackie, Totterdell Susan, Chandelier cartridges in the prefrontal cortex are reduced in isolation reared rats, Synapse, 62, 8, 2008. Crossref

  206. Gallagher Peter, Watson Stuart, Smith Margaret S., Ferrier Ian Nicol, Young Allan H., Effects of adjunctive mifepristone (RU-486) administration on neurocognitive function and symptoms in schizophrenia, Biological Psychiatry, 57, 2, 2005. Crossref

  207. Landgraf Steffen, Amado Isabelle, Brucks Martin, Krueger Frank, Krebs Marie-Odile, van der Meer Elke, Inflexible information acquisition strategies mediate visuo-spatial reasoning in stabilized schizophrenia patients, The World Journal of Biological Psychiatry, 12, 8, 2011. Crossref

  208. Gomes Felipe V., Llorente Ricardo, Del Bel Elaine A., Viveros Maria-Paz, López-Gallardo Meritxell, Guimarães Francisco S., Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol, Schizophrenia Research, 164, 1-3, 2015. Crossref

  209. Drew Liam J., Crabtree Gregg W., Markx Sander, Stark Kimberly L., Chaverneff Florence, Xu Bin, Mukai Jun, Fenelon Karine, Hsu Pei‐Ken, Gogos Joseph A., Karayiorgou Maria, The 22q11.2 microdeletion: Fifteen years of insights into the genetic and neural complexity of psychiatric disorders, International Journal of Developmental Neuroscience, 29, 3, 2011. Crossref

  210. Cellard Caroline, Tremblay Sébastien, Lefèbvre Andrée-Anne, Laplante Louis, Achim Amélie M., Bouchard Roch-Hugo, Roy Marc-André, Insights from the examination of verbal and spatial memory errors in relation to clinical symptoms of patients with recent-onset schizophrenia, Cognitive Neuropsychiatry, 14, 6, 2009. Crossref

  211. Mishara Aaron L, Goldberg Terry E, A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book, Biological Psychiatry, 55, 10, 2004. Crossref

  212. Wölwer Wolfgang, Gaebel Wolfgang, Impaired Trail-Making Test-B performance in patients with acute schizophrenia is related to inefficient sequencing of planning and acting, Journal of Psychiatric Research, 36, 6, 2002. Crossref

  213. Mendelsohn Daniel, Riedel Wim J., Sambeth Anke, Effects of acute tryptophan depletion on memory, attention and executive functions: A systematic review, Neuroscience & Biobehavioral Reviews, 33, 6, 2009. Crossref

  214. Woo Youngsik, Lee Saebom, Jeong Jaehoon, Park Sang Ki, Use of Behavioral Analysis in Animal Models for Schizophrenia Research, Korean Journal of Schizophrenia Research, 17, 1, 2014. Crossref

  215. Thomson P.A., Harris S.E., Starr J.M., Whalley L.J., Porteous D.J., Deary I.J., Association between genotype at an exonic SNP in DISC1 and normal cognitive aging, Neuroscience Letters, 389, 1, 2005. Crossref

  216. Faugère Mélanie, Micoulaud-Franchi Jean-Arthur, Boyer Laurent, Cermolacce Michel, Richieri Raphaëlle, Faget Catherine, Vion-Dury Jean, Lançon Christophe, Does sensory gating have a protective effect against hallucinatory behavior in schizophrenia?, Clinical Neurophysiology, 127, 2, 2016. Crossref

  217. Cui Long-Biao, Liu Jian, Wang Liu-Xian, Li Chen, Xi Yi-Bin, Guo Fan, Wang Hua-Ning, Zhang Lin-Chuan, Liu Wen-Ming, He Hong, Tian Ping, Yin Hong, Lu Hongbing, Anterior cingulate cortex-related connectivity in first-episode schizophrenia: a spectral dynamic causal modeling study with functional magnetic resonance imaging, Frontiers in Human Neuroscience, 9, 2015. Crossref

  218. Kitchen Helen, Rofail Diana, Heron Louise, Sacco Pat, Cognitive Impairment Associated with Schizophrenia: A Review of the Humanistic Burden, Advances in Therapy, 29, 2, 2012. Crossref

  219. Zhang Ying, Cazakoff Brittany N., Thai Chester A., Howland John G., Prenatal exposure to a viral mimetic alters behavioural flexibility in male, but not female, rats, Neuropharmacology, 62, 3, 2012. Crossref

  220. Lipska Barbara K., Gogos Joseph A., Animal Models of Schizophrenia, in Schizophrenia, 2011. Crossref

  221. Diwadkar Vaibhav A., Keshavan Matcheri S., White Matter Pathology, Brain Development, and Psychiatric Disorders: Lessons from Corpus Callosum Studies, in Developmental Psychopathology, 2015. Crossref

  222. Nasif Fernando J., Hu Xiu-Ti, Ramirez Oscar A., Perez Mariela F., Inhibition of neuronal nitric oxide synthase prevents alterations in medial prefrontal cortex excitability induced by repeated cocaine administration, Psychopharmacology, 218, 2, 2011. Crossref

  223. Jędrasik-Styła Małgorzata, Ciołkiewicz Agnieszka, Styła Rafał, Linke Magdalena, Parnowska Dorota, Gruszka Anna, Denisiuk Mirella, Jarema Marek, Green Michael F., Wichniak Adam, The Polish Academic Version of the MATRICS Consensus Cognitive Battery (MCCB): Evaluation of Psychometric Properties, Psychiatric Quarterly, 86, 3, 2015. Crossref

  224. Brown Russell W., Perna Marla K., Maple Amanda M., Wilson Tracy D., Miller Barney E., Adulthood olanzapine treatment fails to alleviate decreases of ChAT and BDNF RNA expression in rats quinpirole-primed as neonates, Brain Research, 1200, 2008. Crossref

  225. Maiti Panchanan, Manna Jayeeta, Ilavazhagan G., Rossignol Julien, Dunbar Gary L., Molecular regulation of dendritic spine dynamics and their potential impact on synaptic plasticity and neurological diseases, Neuroscience & Biobehavioral Reviews, 59, 2015. Crossref

  226. Chen Ce, Jiang Wenhui, Zhong Na, Wu Jin, Jiang Haifeng, Du Jiang, Li Ye, Ma Xiancang, Zhao Min, Hashimoto Kenji, Gao Chengge, Impaired processing speed and attention in first-episode drug naive schizophrenia with deficit syndrome, Schizophrenia Research, 159, 2-3, 2014. Crossref

  227. Oram Joanne, Geffen Gina M., Geffen Laurie B., Kavanagh David J., McGrath John J., Executive control of working memory in schizophrenia, Psychiatry Research, 135, 2, 2005. Crossref

  228. Kargieman Lucila, Riga Maurizio S, Artigas Francesc, Celada Pau, Clozapine Reverses Phencyclidine-Induced Desynchronization of Prefrontal Cortex through a 5-HT1A Receptor-Dependent Mechanism, Neuropsychopharmacology, 37, 3, 2012. Crossref

  229. Meyer Urs, Anti-inflammatory signaling in schizophrenia, Brain, Behavior, and Immunity, 25, 8, 2011. Crossref

  230. Thacker Stephanie K., Perna Marla K., Ward Jeffery J., Schaefer Tori L., Williams Michael T., Kostrzewa Richard M., Brown Russell W., The effects of adulthood olanzapine treatment on cognitive performance and neurotrophic factor content in male and female rats neonatally treated with quinpirole, European Journal of Neuroscience, 24, 7, 2006. Crossref

  231. Heeramun-Aubeeluck Anisha, Liu Na, Fischer Felix, Huang Nan, Chen Fazhan, He Leiying, Yang Chengqing, Luo Yanli, Lu Zheng, Effect of time and duration of untreated psychosis on cognitive and social functioning in Chinese patients with first-episode schizophrenia: A 1-year study, Nordic Journal of Psychiatry, 69, 4, 2015. Crossref

  232. Nishijo Hisao, Hori Etsuro, Tazumi Toru, Ono Taketoshi, Neural correlates to both emotion and cognitive functions in the monkey amygdala, Behavioural Brain Research, 188, 1, 2008. Crossref

  233. Straub Richard E., Jiang Yuxin, MacLean Charles J., Ma Yunlong, Webb Bradley T., Myakishev Maxim V., Harris-Kerr Carole, Wormley Brandon, Sadek Hannah, Kadambi Bharat, Cesare Anthony J., Gibberman Avi, Wang Xu, O'Neill F. Anthony, Walsh Dermot, Kendler Kenneth S., Genetic Variation in the 6p22.3 Gene DTNBP1, the Human Ortholog of the Mouse Dysbindin Gene, Is Associated with Schizophrenia, The American Journal of Human Genetics, 71, 2, 2002. Crossref

  234. McLeod Hamish J., Wood Nikki, Brewin Chris R., Autobiographical memory deficits in schizophrenia, Cognition and Emotion, 20, 3-4, 2006. Crossref

  235. McLean Samantha L., Beck Jonathan P., Woolley Marie L., Neill Joanna C., A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats, Behavioural Brain Research, 189, 1, 2008. Crossref

  236. Becker Axel, Grecksch Gisela, Pharmacological treatment to augment hole board habituation in prenatal Vitamin D-deficient rats, Behavioural Brain Research, 166, 1, 2006. Crossref

  237. Jentsch J.David, Pre-clinical models of cognitive dysfunction in schizophrenia: new avenues to addressing unmet needs, Clinical Neuroscience Research, 3, 4-5, 2003. Crossref

  238. Amitai Nurith, Markou Athina, Disruption of Performance in the Five-Choice Serial Reaction Time Task Induced By Administration of N-Methyl-D-Aspartate Receptor Antagonists: Relevance to Cognitive Dysfunction in Schizophrenia, Biological Psychiatry, 68, 1, 2010. Crossref

  239. Dusi N., Bellani M., Perlini C., Squarcina L., Marinelli V., Finos L., Altamura C.A., Ruggeri M., Brambilla P., Progressive disability and prefrontal shrinkage in schizophrenia patients with poor outcome: A 3-year longitudinal study, Schizophrenia Research, 179, 2017. Crossref

  240. Chang Chia-Yuan, Chen Yi-Wen, Wang Tsu-Wei, Lai Wen-Sung, Akting up in the GABA hypothesis of schizophrenia: Akt1 deficiency modulates GABAergic functions and hippocampus-dependent functions, Scientific Reports, 6, 1, 2016. Crossref

  241. Garcia-Alvarez Leticia, Garcia-Portilla Maria Paz, Gonzalez-Blanco Leticia, Saiz Martinez Pilar Alejandra, de la Fuente-Tomas Lorena, Menendez-Miranda Isabel, Iglesias Celso, Bobes Julio, Biomarcadores sanguíneos diferenciales de las dimensiones psicopatológicas de la esquizofrenia, Revista de Psiquiatría y Salud Mental, 9, 4, 2016. Crossref

  242. Alloza Clara, Cox Simon R., Duff Barbara, Semple Scott I., Bastin Mark E., Whalley Heather C., Lawrie Stephen M., Information processing speed mediates the relationship between white matter and general intelligence in schizophrenia, Psychiatry Research: Neuroimaging, 254, 2016. Crossref

  243. Chapman Justin J., Fraser Sarah J., Brown Wendy J., Burton Nicola W., Physical activity preferences, motivators, barriers and attitudes of adults with mental illness, Journal of Mental Health, 25, 5, 2016. Crossref

  244. Siebenhühner Felix, Weiss Shennan A., Coppola Richard, Weinberger Daniel R., Bassett Danielle S., Hayasaka Satoru, Intra- and Inter-Frequency Brain Network Structure in Health and Schizophrenia, PLoS ONE, 8, 8, 2013. Crossref

  245. Elvevåg Brita, Maylor Elizabeth A, Gilbert Abigail L, Habitual prospective memory in schizophrenia, BMC Psychiatry, 3, 1, 2003. Crossref

  246. Zhang Xiang Yang, Chen Da Chun, Xiu Mei Hong, Haile Colin N., Sun Hongqiang, Lu Lin, Kosten Therese A., Kosten Thomas R., Boraud Thomas, Cigarette Smoking and Cognitive Function in Chinese Male Schizophrenia: A Case-Control study, PLoS ONE, 7, 5, 2012. Crossref

  247. Wang Yiqing, Zhang Peng, Wyskiel Daniel R., Chandelier Cells in Functional and Dysfunctional Neural Circuits, Frontiers in Neural Circuits, 10, 2016. Crossref

  248. Baumstarck Karine, Boucekine Mohamed, Boyer Laurent, Aghababian Valérie, Parola Nathalie, Reuter Françoise, Loundou Anderson, Lançon Christophe, Pelletier Jean, Auquier Pascal, Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices, BMC Neurology, 14, 1, 2014. Crossref

  249. Mahato Akash, Halder Susmita, Disability in Schizophrenia, in Chronic Mental Illness and the Changing Scope of Intervention Strategies, Diagnosis, and Treatment, 2017. Crossref

  250. Stone William S., Seidman Larry J., Neuropsychological and Structural Neuroimaging Endophenotypes in Schizophrenia, in Developmental Psychopathology, 2016. Crossref

  251. Miyanishi Tomohiro, Sumiyoshi Tomiki, Higuchi Yuko, Seo Tomonori, Suzuki Michio, Hashimoto Kenji, LORETA Current Source Density for Duration Mismatch Negativity and Neuropsychological Assessment in Early Schizophrenia, PLoS ONE, 8, 4, 2013. Crossref

  252. Mazzoncini Rodolfo, Zoli Michele, Tosato Sarah, Lasalvia Antonio, Ruggeri Mirella, Can the role of genetic factors in schizophrenia be enlightened by studies of candidate gene mutant mice behaviour?, The World Journal of Biological Psychiatry, 10, 4-3, 2009. Crossref

  253. Gomes Felipe V., Rincón-Cortés Millie, Grace Anthony A., Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model, Neuroscience & Biobehavioral Reviews, 70, 2016. Crossref

  254. Faerden Ann, Vaskinn Anja, Finset Arnstein, Agartz Ingrid, Ann Barrett Elizabeth, Friis Svein, Simonsen Carmen, Andreassen Ole A, Melle Ingrid, Apathy is associated with executive functioning in first episode psychosis, BMC Psychiatry, 9, 1, 2009. Crossref

  255. Bortz D.M., Upton B.A., Mikkelsen J.D., Bruno J.P., Positive allosteric modulators of the α7 nicotinic acetylcholine receptor potentiate glutamate release in the prefrontal cortex of freely-moving rats, Neuropharmacology, 111, 2016. Crossref

  256. Santos-Toscano Raquel, Borcel Érika, Ucha Marcos, Orihuel Javier, Capellán Roberto, Roura-Martínez David, Ambrosio Emilio, Higuera-Matas Alejandro, Unaltered cocaine self-administration in the prenatal LPS rat model of schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 69, 2016. Crossref

  257. Gallagher Peter, Massey Anna E, Young Allan H, McAllister-Williams R Hamish, Effects of acute tryptophan depletion on executive function in healthy male volunteers, BMC Psychiatry, 3, 1, 2003. Crossref

  258. Woodcock Eric A., Wadehra Sunali, Diwadkar Vaibhav A., Network Profiles of the Dorsal Anterior Cingulate and Dorsal Prefrontal Cortex in Schizophrenia During Hippocampal-Based Associative Memory, Frontiers in Systems Neuroscience, 10, 2016. Crossref

  259. Kärgel Christian, Sartory Gudrun, Kariofillis Daniela, Wiltfang Jens, Müller Bernhard W., Snyder Joel, Mismatch Negativity Latency and Cognitive Function in Schizophrenia, PLoS ONE, 9, 4, 2014. Crossref

  260. Tcheremissine Oleg V, Castro Manuel A, Gardner Dineen R, Targeting cognitive deficits in schizophrenia: a review of the development of a new class of medicines from the perspective of community mental health researchers, Expert Opinion on Investigational Drugs, 21, 1, 2012. Crossref

  261. Long Leonora E., Anderson Paul, Frank Elisabeth, Shaw Alex, Liu Shijie, Huang Xu-Feng, Pinault Didier, Karl Tim, O’Brien Terence J., Shannon Weickert Cynthia, Jones Nigel C., Hashimoto Takanori, Neuregulin 1 Expression and Electrophysiological Abnormalities in the Neuregulin 1 Transmembrane Domain Heterozygous Mutant Mouse, PLOS ONE, 10, 5, 2015. Crossref

  262. Rademeyer Mia, Joubert Pierre, A comparison between the Mini-Mental State Examination and the Montreal Cognitive Assessment Test in schizophrenia, South African Journal of Psychiatry, 22, 1, 2016. Crossref

  263. Kärgel Christian, Sartory Gudrun, Kariofillis Daniela, Wiltfang Jens, Müller Bernhard W., The effect of auditory and visual training on the mismatch negativity in schizophrenia, International Journal of Psychophysiology, 102, 2016. Crossref

  264. Pagsberg Anne Katrine, Jeppesen Pia, Klauber Dea Gowers, Jensen Karsten Gjessing, Rudå Ditte, Stentebjerg-Olesen Marie, Jantzen Peter, Rasmussen Simone, Saldeen Eva Ann-Sofie, Lauritsen Maj-Britt Glenn, Bilenberg Niels, Stenstrøm Anne Dorte, Pedersen Jesper, Nyvang Louise, Madsen Sarah, Lauritsen Marlene B, Vernal Ditte Lammers, Thomsen Per Hove, Paludan Jakob, Werge Thomas M, Winge Kristian, Juul Klaus, Gluud Christian, Skoog Maria, Wetterslev Jørn, Jepsen Jens Richardt M, Correll Christoph U, Fink-Jensen Anders, Fagerlund Birgitte, Quetiapine versus aripiprazole in children and adolescents with psychosis - protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial, BMC Psychiatry, 14, 1, 2014. Crossref

  265. Liu Weiqing, Wang Dong, Hong Wenjuan, Yu Yi, Tang Jinsong, Wang Jicai, Liu Fang, Xu Xiufeng, Tan Liwen, Chen Xiaogang, Psychotomimetic effects of different doses of MK-801 and the underlying mechanisms in a selective memory impairment model, Behavioural Brain Research, 320, 2017. Crossref

  266. Zhang Chen, The involvement of family members in the treatment of patients with schizophrenia, Current Treatment Options in Psychiatry, 3, 2, 2016. Crossref

  267. Garcia-Alvarez Leticia, Garcia-Portilla Maria Paz, Gonzalez-Blanco Leticia, Saiz Martinez Pilar Alejandra, de la Fuente-Tomas Lorena, Menendez-Miranda Isabel, Iglesias Celso, Bobes Julio, Differential blood-based biomarkers of psychopathological dimensions of schizophrenia, Revista de Psiquiatría y Salud Mental (English Edition), 9, 4, 2016. Crossref

  268. Becker Axel, Modeling Schizophrenia: Focus on Developmental Models, in In Vivo Neuropharmacology and Neurophysiology, 121, 2017. Crossref

  269. Andric Sanja, Maric Nadja P., Mihaljevic Marina, Mirjanic Tijana, van Os Jim, Familial covariation of facial emotion recognition and IQ in schizophrenia, Psychiatry Research, 246, 2016. Crossref

  270. Xi Yi-Bin, Li Chen, Cui Long-Biao, Liu Jian, Guo Fan, Li Liang, Liu Ting-Ting, Liu Kang, Chen Gang, Xi Min, Wang Hua-Ning, Yin Hong, Anterior Cingulate Cortico-Hippocampal Dysconnectivity in Unaffected Relatives of Schizophrenia Patients: A Stochastic Dynamic Causal Modeling Study, Frontiers in Human Neuroscience, 10, 2016. Crossref

  271. Potasiewicz Agnieszka, Hołuj Małgorzata, Kos Tomasz, Popik Piotr, Arias Hugo R., Nikiforuk Agnieszka, 3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats, Neuropharmacology, 113, 2017. Crossref

  272. Green Amity E., Croft Rodney J., Maller Jerome J., Fitzgerald Paul B., White matter correlates of episodic memory encoding and retrieval in schizophrenia, Psychiatry Research: Neuroimaging, 254, 2016. Crossref

  273. Bulzacka Ewa, Boyer Laurent, Schürhoff Franck, Godin Ophélia, Berna Fabrice, Brunel Lore, Andrianarisoa Méja, Aouizerate Bruno, Capdevielle Delphine, Chéreau-Boudet Isabelle, Chesnoy-Servanin Gabrielle, Danion Jean-Marie, Dubertret Caroline, Dubreucq Julien, Faget Catherine, Gabayet Franck, Le Gloahec Tifenn, Llorca Pierre-Michel, Mallet Jasmina, Misdrahi David, Rey Romain, Richieri Raphaëlle, Passerieux Christine, Roux Paul, Yazbek Hanan, Leboyer Marion, Fond Guillaume, Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset, Schizophrenia Bulletin, 42, 5, 2016. Crossref

  274. Ni Yu-Fei, Zhang Wei, Bao Xiao-Feng, Wang Wei, Song Lu, Jiang Bo, GM1 ganglioside reverses the cognitive deficits induced by MK801 in mice, Behavioural Pharmacology, 27, 5, 2016. Crossref

  275. Rompala Gregory R., Zsiros Veronika, Zhang Shuqin, Kolata Stefan M., Nakazawa Kazu, Yoshikawa Takeo, Contribution of NMDA Receptor Hypofunction in Prefrontal and Cortical Excitatory Neurons to Schizophrenia-Like Phenotypes, PLoS ONE, 8, 4, 2013. Crossref

  276. Stratton John, Brook Michael, Hanlon Robert E., Murder and psychosis: Neuropsychological profiles of homicide offenders with schizophrenia, Criminal Behaviour and Mental Health, 27, 2, 2017. Crossref

  277. Huang Man-Li, Khoh Thong-Teck, Lu Shao-Jia, Pan Fen, Chen Jin-Kai, Hu Jian-Bo, Hu Shao-Hua, Xu Wei-Juan, Zhou Wei-Hua, Wei Ning, Qi Hong-Li, Shang De-Sheng, Xu Yi, Relationships between dorsolateral prefrontal cortex metabolic change and cognitive impairment in first-episode neuroleptic-naive schizophrenia patients, Medicine, 96, 25, 2017. Crossref

  278. Humpston Clara S., Linden David E.J., Evans Lisa H., Deficits in reality and internal source monitoring of actions are associated with the positive dimension of schizotypy, Psychiatry Research, 250, 2017. Crossref

  279. Hardcastle Valerie Gray, Predicting the Self: Lessons from Schizophrenia, Review of Philosophy and Psychology, 10, 2, 2019. Crossref

  280. Fleischman Anat, Lurie Ido, Cardiovascular Mortality and Related Risk Factors among Persons with Schizophrenia: A Review of the Published Literature, Public Health Reviews, 34, 2, 2012. Crossref

  281. Talbot Konrad, Louneva Natalia, Cohen Julia W., Kazi Hala, Blake Derek J., Arnold Steven E., Ginsberg Stephen, Synaptic Dysbindin-1 Reductions in Schizophrenia Occur in an Isoform-Specific Manner Indicating Their Subsynaptic Location, PLoS ONE, 6, 3, 2011. Crossref

  282. Jagannath Vinita, Gerstenberg Miriam, Correll Christoph U., Walitza Susanne, Grünblatt Edna, A systematic meta-analysis of the association of Neuregulin 1 (NRG1), d-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia, Journal of Neural Transmission, 125, 1, 2018. Crossref

  283. Mathias Samuel R., Knowles Emma E. M., Barrett Jennifer, Leach Olivia, Buccheri Sebastiano, Beetham Tamara, Blangero John, Poldrack Russell A., Glahn David. C., The Processing-Speed Impairment in Psychosis Is More Than Just Accelerated Aging, Schizophrenia Bulletin, 2017. Crossref

  284. Chen Guoliang, Ding Weiyan, Zhang Lei, Cui Hong, Jiang Zhongdong, Li Yansong, Neurophysiological Evidence of Compensatory Brain Mechanisms Underlying Attentional-Related Processes in Symptomatically Remitted Patients with Schizophrenia, Frontiers in Psychology, 8, 2017. Crossref

  285. Geerts Hugo, Roberts Patrick, Spiros Athan, Potkin Steven, Understanding responder neurobiology in schizophrenia using a quantitative systems pharmacology model: Application to iloperidone, Journal of Psychopharmacology, 29, 4, 2015. Crossref

  286. Moran Lauren V., Stoeckel Luke E., Wang Kristina, Caine Carolyn E., Villafuerte Rosemond, Calderon Vanessa, Baker Justin T., Ongur Dost, Janes Amy C., Evins A. Eden, Pizzagalli Diego A., Nicotine-induced activation of caudate and anterior cingulate cortex in response to errors in schizophrenia, Psychopharmacology, 235, 3, 2018. Crossref

  287. Uys Madeleine Monique, Shahid Mohammed, Harvey Brian Herbert, Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia—New Developments and Future Perspective, Frontiers in Psychiatry, 8, 2017. Crossref

  288. Marinho Victor, Oliveira Thomaz, Rocha Kaline, Ribeiro Jéssica, Magalhães Francisco, Bento Thalys, Pinto Giovanny R., Velasques Bruna, Ribeiro Pedro, Di Giorgio Luiza, Orsini Marco, Gupta Daya S., Bittencourt Juliana, Bastos Victor Hugo, Teixeira Silmar, The dopaminergic system dynamic in the time perception: a review of the evidence, International Journal of Neuroscience, 128, 3, 2018. Crossref

  289. McLean SL, Grayson B., Harris M., Protheroe C., Woolley ML, Neill JC, Isolation rearing impairs novel object recognition and attentional set shifting performance in female rats, Journal of Psychopharmacology, 24, 1, 2010. Crossref

  290. Cano-Colino Maria, Almeida Rita, Gomez-Cabrero David, Artigas Francesc, Compte Albert, Serotonin Regulates Performance Nonmonotonically in a Spatial Working Memory Network, Cerebral Cortex, 24, 9, 2014. Crossref

  291. Ragan Chikako, Patel Kalpana, Edson Janette, Zhang Zong-Hong, Gratten Jacob, Mowry Bryan, Small non-coding RNA expression from anterior cingulate cortex in schizophrenia shows sex specific regulation, Schizophrenia Research, 183, 2017. Crossref

  292. Nikiforuk Agnieszka, Kos Tomasz, Fijał Katarzyna, Hołuj Małgorzata, Rafa Dominik, Popik Piotr, Hashimoto Kenji, Effects of the Selective 5-HT7 Receptor Antagonist SB-269970 and Amisulpride on Ketamine-Induced Schizophrenia-like Deficits in Rats, PLoS ONE, 8, 6, 2013. Crossref

  293. Vyas Nora S, Shamsi Syed A, Malhotra Anil K, Aitchison Katherine J, Kumari Veena, Can genetics inform the management of cognitive deficits in schizophrenia?, Journal of Psychopharmacology, 26, 3, 2012. Crossref

  294. Georgiades Anastasia, Davis Vicki G., Atkins Alexandra S., Khan Anzalee, Walker Trina W., Loebel Antony, Haig George, Hilt Dana C., Dunayevich Eduardo, Umbricht Daniel, Sand Michael, Keefe Richard S.E., Psychometric characteristics of the MATRICS Consensus Cognitive Battery in a large pooled cohort of stable schizophrenia patients, Schizophrenia Research, 190, 2017. Crossref

  295. Reich Catherine M., Hack Samantha M., Klingaman Elizabeth A., Brown Clayton H., Fang Li Juan, Dixon Lisa B., Jahn Danielle R., Kreyenbuhl Julie A., Consumer satisfaction with antipsychotic medication-monitoring appointments: the role of consumer–prescriber communication patterns, International Journal of Psychiatry in Clinical Practice, 22, 2, 2018. Crossref

  296. Mereu M., Contarini G., Buonaguro E.F., Latte G., Managò F., Iasevoli F., de Bartolomeis A., Papaleo F., Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder, Neuropharmacology, 121, 2017. Crossref

  297. Yu Rongjun, Hsieh Ming H., Wang Hsiao-Lan Sharon, Liu Chih-Min, Liu Chen-Chung, Hwang Tzung-Jeng, Chien Yi-Ling, Hwu Hai-Gwo, Tseng Wen-Yih Isaac, Baune Bernhard T., Frequency Dependent Alterations in Regional Homogeneity of Baseline Brain Activity in Schizophrenia, PLoS ONE, 8, 3, 2013. Crossref

  298. Impey Danielle, Baddeley Ashley, Nelson Renee, Labelle Alain, Knott Verner, Effects of transcranial direct current stimulation on the auditory mismatch negativity response and working memory performance in schizophrenia: a pilot study, Journal of Neural Transmission, 124, 11, 2017. Crossref

  299. Hsu Ruby, Woodroffe Abigail, Lai Wen-Sung, Cook Melloni N., Mukai Jun, Dunning Jonathan P., Swanson Douglas J., Roos J. Louw, Abecasis Gonçalo R., Karayiorgou Maria, Gogos Joseph A., Baune Bernhard, Nogo Receptor 1 (RTN4R) as a Candidate Gene for Schizophrenia: Analysis Using Human and Mouse Genetic Approaches, PLoS ONE, 2, 11, 2007. Crossref

  300. Nikiforuk Agnieszka, Fijał Katarzyna, Potasiewicz Agnieszka, Popik Piotr, Kos Tomasz, The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats, Journal of Psychopharmacology, 27, 5, 2013. Crossref

  301. Fonseca Ana Olívia, Berberian Arthur A., de Meneses-Gaya Carolina, Gadelha Ary, Vicente Marcella de O., Nuechterlein Keith H., Bressan Rodrigo A., Lacerda Acioly L.T., The Brazilian standardization of the MATRICS consensus cognitive battery (MCCB): Psychometric study, Schizophrenia Research, 185, 2017. Crossref

  302. Murray John D., Wang Xiao-Jing, Cortical Circuit Models in Psychiatry, in Computational Psychiatry, 2018. Crossref

  303. Prasad Konasale M., Eack Shaun M., Keshavan Matcheri S., Yolken Robert H., Iyengar Satish, Nimgaonkar Vishwajit L., Antiherpes Virus–Specific Treatment and Cognition in Schizophrenia: A Test-of-Concept Randomized Double-Blind Placebo-Controlled Trial, Schizophrenia Bulletin, 39, 4, 2013. Crossref

  304. Noh Haneul, Shao Zhicheng, Coyle Joseph T., Chung Sangmi, Modeling schizophrenia pathogenesis using patient-derived induced pluripotent stem cells (iPSCs), Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1863, 9, 2017. Crossref

  305. Campos Alline C., Fogaça Manoela V., Scarante Franciele F., Joca Sâmia R. L., Sales Amanda J., Gomes Felipe V., Sonego Andreza B., Rodrigues Naielly S., Galve-Roperh Ismael, Guimarães Francisco S., Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders, Frontiers in Pharmacology, 8, 2017. Crossref

  306. Loch Alexandre A., van de Bilt Martinus T., Bio Danielle S., Prado Carolina M. do, Sousa Rafael T. de, Valiengo Leandro L., Moreno Ricardo A., Zanetti Marcus V., Gattaz Wagner F., Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission, Brazilian Journal of Psychiatry, 37, 3, 2015. Crossref

  307. Elvevåg Brita, Storms Gert, Scaling and clustering in the study of semantic disruptions in patients with schizophrenia: a re-evaluation, Schizophrenia Research, 63, 3, 2003. Crossref

  308. Zhou Yujing, Ma Xiaomei, Wang Di, Qin Wen, Zhu Jiajia, Zhuo Chuanjun, Yu Chunshui, Liu Yong, The Selective Impairment of Resting-State Functional Connectivity of the Lateral Subregion of the Frontal Pole in Schizophrenia, PLOS ONE, 10, 3, 2015. Crossref

  309. Zhang Baohua, Han Mei, Tan Shuping, De Yang Fu, Tan Yunlong, Jiang Shurong, Zhang Xiangyang, Huang Xu-Feng, Gender differences measured by the MATRICS consensus cognitive battery in chronic schizophrenia patients, Scientific Reports, 7, 1, 2017. Crossref

  310. Miyauchi Masanori, Neugebauer Nichole M, Sato Tatsuya, Ardehali Hossein, Meltzer Herbert Y, Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats, Journal of Psychopharmacology, 31, 12, 2017. Crossref

  311. Ikeda Masashi, Hikita Takao, Taya Shinichiro, Uraguchi-Asaki Junko, Toyo-oka Kazuhito, Wynshaw-Boris Anthony, Ujike Hiroshi, Inada Toshiya, Takao Keizo, Miyakawa Tsuyoshi, Ozaki Norio, Kaibuchi Kozo, Iwata Nakao, Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia, Human Molecular Genetics, 17, 20, 2008. Crossref

  312. Fond Guillaume, Berna F., Boyer L., Godin O., Brunel L., Andrianarisoa M., Aouizerate B., Capdevielle D., Chereau I., Danion J. M., Dubertret C., Dubreucq J., Faget C., Gabayet F., Le Gloahec T., Llorca P. M., Mallet J., Misdrahi D., Rey R., Richieri R., Passerieux C., Portalier C., Roux P., Vehier A., Yazbek H., Schürhoff F., Bulzacka E., Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set, European Archives of Psychiatry and Clinical Neuroscience, 268, 1, 2018. Crossref

  313. Moore Elizabeth, Mancuso Serafino G, Slade Tim, Galletly Cherrie, Castle David J, The impact of alcohol and illicit drugs on people with psychosis: The second Australian national survey of psychosis, Australian & New Zealand Journal of Psychiatry, 46, 9, 2012. Crossref

  314. Hidese Shinsuke, Ota Miho, Matsuo Junko, Ishida Ikki, Hiraishi Moeko, Teraishi Toshiya, Hattori Kotaro, Kunugi Hiroshi, Association between the scores of the Japanese version of the Brief Assessment of Cognition in Schizophrenia and whole-brain structure in patients with chronic schizophrenia: A voxel-based morphometry and diffusion tensor imaging study, Psychiatry and Clinical Neurosciences, 71, 12, 2017. Crossref

  315. Bortz D.M., Wu H.-Q., Schwarcz R., Bruno J.P., Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex, Neuropharmacology, 121, 2017. Crossref

  316. Wiecki Thomas V., Poland Jeffrey, Frank Michael J., Model-Based Cognitive Neuroscience Approaches to Computational Psychiatry, Clinical Psychological Science, 3, 3, 2015. Crossref

  317. Shen Christina, Popescu Florin C., Hahn Eric, Ta Tam T.M., Dettling Michael, Neuhaus Andres H., Neurocognitive Pattern Analysis Reveals Classificatory Hierarchy of Attention Deficits in Schizophrenia, Schizophrenia Bulletin, 40, 4, 2014. Crossref

  318. Lee Posen, Lu Wen-Shian, Liu Chin-Hsuan, Lin Hung-Yu, Hsieh Ching-Lin, Test–Retest Reliability and Minimal Detectable Change of the D2 Test of Attention in Patients with Schizophrenia, Archives of Clinical Neuropsychology, 33, 8, 2018. Crossref

  319. Yang Jian-Ming, Shen Chen-Jie, Chen Xiao-Juan, Kong Ying, Liu Yi-Si, Li Xiao-Wen, Chen Zhong, Gao Tian-Ming, Li Xiao-Ming, erbb4 Deficits in Chandelier Cells of the Medial Prefrontal Cortex Confer Cognitive Dysfunctions: Implications for Schizophrenia, Cerebral Cortex, 29, 10, 2019. Crossref

  320. Keshavan Matcheri S., Cashmere J.David, Miewald Jean, Yeragani Vikram Kumar, Decreased nonlinear complexity and chaos during sleep in first episode schizophrenia: a preliminary report, Schizophrenia Research, 71, 2-3, 2004. Crossref

  321. MacKenzie Nicole E., Kowalchuk Chantel, Agarwal Sri Mahavir, Costa-Dookhan Kenya A., Caravaggio Fernando, Gerretsen Philip, Chintoh Araba, Remington Gary J., Taylor Valerie H., Müeller Daniel J., Graff-Guerrero Ariel, Hahn Margaret K., Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia, Frontiers in Psychiatry, 9, 2018. Crossref

  322. Suzuki T., Iwata N., Kitamura Y., Kitajima T., Yamanouchi Y., Ikeda M., Nishiyama T., Kamatani N., Ozaki N., Association of a haplotype in the serotonin 5-HT4 receptor gene (HTR4) with Japanese schizophrenia, American Journal of Medical Genetics, 121B, 1, 2003. Crossref

  323. Schroeder Ryan W., Marshall Paul S., Evaluation of the Appropriateness of Multiple Symptom Validity Indices in Psychotic and Non-Psychotic Psychiatric Populations, The Clinical Neuropsychologist, 25, 3, 2011. Crossref

  324. Fuermaier Anselm B.M., Piersma Dafne, Huntjens Rafaele J.C., de Waard Dick, Westermann Celina, Bossert Magdalena, Lange Klaus W., Weisbrod Matthias, Bruggeman Richard, Aschenbrenner Steffen, Tucha Oliver, Simulated car driving and its association with cognitive abilities in patients with schizophrenia, Schizophrenia Research, 204, 2019. Crossref

  325. Vanzetti Marie, Bulzacka Ewa, Delourme Gwenaelle, Dupuis Marie, Josserand Anne-Claire, Pousthomis Malgorzata, Évaluation subjective de l'autonomie et mise en situation écologique, in Traité de Réhabilitation Psychosociale, 2018. Crossref

  326. Huang Lin-Jye, Hu Fu-Chang, Wu Chinyu, Yang Yi-Hong, Lee Shu-Chun, Fang Yung-Chun, Huang Hsu-Chang, Lai Kuan-Yu, Yu Chun-Yi, Traditional-Chinese Dispositional Flow Scale-2 and Flow State Scale-2 in Taiwanese subjects with schizophrenia or schizoaffective disorder, Psychiatry Research, 274, 2019. Crossref

  327. Elvevåg Brita, Brown Gordon D. A., McCormack Teresa, Vousden Janet I., Goldberg Terry E., Identification of Tone Duration, Line Length, and Letter Position: An Experimental Approach to Timing and Working Memory Deficits in Schizophrenia., Journal of Abnormal Psychology, 113, 4, 2004. Crossref

  328. Uttl Libor, Petrasek Tomas, Sengul Hilal, Svojanovska Marketa, Lobellova Veronika, Vales Karel, Radostova Dominika, Tsenov Grygoriy, Kubova Hana, Mikulecka Anna, Svoboda Jan, Stuchlik Ales, Chronic MK-801 Application in Adolescence and Early Adulthood: A Spatial Working Memory Deficit in Adult Long-Evans Rats But No Changes in the Hippocampal NMDA Receptor Subunits, Frontiers in Pharmacology, 9, 2018. Crossref

  329. Lewis David A., Hashimoto Takanori, Volk David W., Cortical inhibitory neurons and schizophrenia, Nature Reviews Neuroscience, 6, 4, 2005. Crossref

  330. Kravariti Eugenia, Morgan Kevin, Fearon Paul, Zanelli Jolanta W., Lappin Julia M., Dazzan Paola, Morgan Craig, Doody Gillian A., Harrison Glynn, Jones Peter B., Murray Robin M., Reichenberg Abraham, Neuropsychological functioning in first-episode schizophrenia, British Journal of Psychiatry, 195, 4, 2009. Crossref

  331. Rund Bjorn Rishovd, The research evidence for schizophrenia as a neurodevelopmental disorder, Scandinavian Journal of Psychology, 59, 1, 2018. Crossref

  332. Shon Seung-Hyun, Yoon Woon, Kim Harin, Joo Sung Woo, Kim Yangsik, Lee Jungsun, Deterioration in Global Organization of Structural Brain Networks in Schizophrenia: A Diffusion MRI Tractography Study, Frontiers in Psychiatry, 9, 2018. Crossref

  333. Lin Yen-Feng, Chen Chia-Yen, Öngür Dost, Betensky Rebecca, Smoller Jordan W., Blacker Deborah, Hall Mei-Hua, Polygenic pleiotropy and potential causal relationships between educational attainment, neurobiological profile, and positive psychotic symptoms, Translational Psychiatry, 8, 1, 2018. Crossref

  334. Chen Xingui, Ji Gong-Jun, Zhu Chunyan, Bai Xiaomeng, Wang Lu, He Kongliang, Gao Yaxiang, Tao Longxiang, Yu Fengqiong, Tian Yanghua, Wang Kai, Neural Correlates of Auditory Verbal Hallucinations in Schizophrenia and the Therapeutic Response to Theta-Burst Transcranial Magnetic Stimulation, Schizophrenia Bulletin, 45, 2, 2019. Crossref

  335. Scarr Elizabeth, Pavey Geoffrey, Copolov David, Dean Brian, Hippocampal 5-hydroxytryptamine receptors: abnormalities in postmortem brain from schizophrenic subjects, Schizophrenia Research, 71, 2-3, 2004. Crossref

  336. Cattapan-Ludewig K., Ludewig S., Jaquenoud Sirot E., Etzensberger M., Hasler F., Warum rauchen Schizophreniepatienten?, Der Nervenarzt, 76, 3, 2005. Crossref

  337. Schurle Bruce Amanda, Ray William J., Bruce Jared M., Arnett Peter A., Carlson Richard A., The relationship between executive functioning and dissociation, Journal of Clinical and Experimental Neuropsychology, 29, 6, 2007. Crossref

  338. Yolland Caitlin O. B., Phillipou Andrea, Castle David J., Neill Erica, Hughes Matthew E., Galletly Cherrie, Smith Zoe M., Francis Paul S., Dean Olivia M., Sarris Jerome, Siskind Dan, Harris Anthony W. F., Rossell Susan L., Improvement of cognitive function in schizophrenia with N-acetylcysteine: A theoretical review, Nutritional Neuroscience, 23, 2, 2020. Crossref

  339. Borkar Chandrashekhar D., Bharne Ashish P., Nagalakshmi B., Sakharkar Amul J., Subhedar Nishikant K., Kokare Dadasaheb M., Cocaine- and Amphetamine-Regulated Transcript Peptide (CART) Alleviates MK-801-Induced Schizophrenic Dementia-Like Symptoms, Neuroscience, 375, 2018. Crossref

  340. King Bryan H., Psychopharmacology in mental retardation, Current Opinion in Psychiatry, 15, 5, 2002. Crossref

  341. Liu Shengfeng, Wang Haiying, Song Ming, Lv Luxian, Cui Yue, Liu Yong, Fan Lingzhong, Zuo Nianming, Xu Kaibin, Du Yuhui, Yu Qingbao, Luo Na, Qi Shile, Yang Jian, Xie Sangma, Li Jian, Chen Jun, Chen Yunchun, Wang Huaning, Guo Hua, Wan Ping, Yang Yongfeng, Li Peng, Lu Lin, Yan Hao, Yan Jun, Wang Huiling, Zhang Hongxing, Zhang Dai, Calhoun Vince D, Jiang Tianzi, Sui Jing, Linked 4-Way Multimodal Brain Differences in Schizophrenia in a Large Chinese Han Population, Schizophrenia Bulletin, 45, 2, 2019. Crossref

  342. Reichenberg Abraham, Weiser Mark, Caspi Asaf, Knobler Haim Y., Lubin Gad, Harvey Philip D., Rabinowitz Jonathan, Davidson Michael, Premorbid Intellectual Functioning and Risk of Schizophrenia and Spectrum Disorders, Journal of Clinical and Experimental Neuropsychology, 28, 2, 2006. Crossref

  343. Egerton Alice, Reid Lee, McKerchar Clare E., Morris Brian J., Pratt Judith A., Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia, Psychopharmacology, 179, 1, 2005. Crossref

  344. Scheunemann Lisa, Plaçais Pierre-Yves, Dromard Yann, Schwärzel Martin, Preat Thomas, Dunce Phosphodiesterase Acts as a Checkpoint for Drosophila Long-Term Memory in a Pair of Serotonergic Neurons, Neuron, 98, 2, 2018. Crossref

  345. Jakaria Md., Cho Duk-Yeon, Ezazul Haque Md., Karthivashan Govindarajan, Kim In-Su, Ganesan Palanivel, Choi Dong-Kug, Neuropharmacological Potential and Delivery Prospects of Thymoquinone for Neurological Disorders, Oxidative Medicine and Cellular Longevity, 2018, 2018. Crossref

  346. Lajiness-O’Neill1 Renée R., Beaulieu Isabelle, Titus Jeffrey B., Asamoah Alexander, Bigler Erin D., Bawle Erawati V., Pollack Rebecca, Memory and Learning in Children with 22q11.2 Deletion Syndrome: Evidence for Ventral and Dorsal Stream Disruption?, Child Neuropsychology, 11, 1, 2005. Crossref

  347. Glausier Jill R., Lewis David A., Mapping pathologic circuitry in schizophrenia, in Brain Banking, 150, 2018. Crossref

  348. Cariaga-Martinez Ariel , Gutiérrez Kilian, Alelú-Paz Raúl, Rethinking schizophrenia through the lens of evolution: shedding light on the enigma, Research Ideas and Outcomes, 4, 2018. Crossref

  349. Schulte Joran T., Wierenga Corette J., Bruining Hilgo, Chloride transporters and GABA polarity in developmental, neurological and psychiatric conditions, Neuroscience & Biobehavioral Reviews, 90, 2018. Crossref

  350. Al-Shammari Abeer R., Bhardwaj Sanjeev K., Musaelyan Ksenia, Srivastava Lalit K., Szele Francis G., Schizophrenia-related dysbindin-1 gene is required for innate immune response and homeostasis in the developing subventricular zone, npj Schizophrenia, 4, 1, 2018. Crossref

  351. Sun Li-lan, Yang Tao-yi, Wei Ning-ning, Lu Wei, Jiao Wen-xuan, Zhou Qi-qi, Miao Yong-zhen, Gao Qin, Wang Xin-tong, Sun Qi, Wang KeWei, Pharmacological characterization of JWX-A0108 as a novel type I positive allosteric modulator of α7 nAChR that can reverse acoustic gating deficits in a mouse prepulse inhibition model, Acta Pharmacologica Sinica, 40, 6, 2019. Crossref

  352. Wearne Travis A., Cornish Jennifer L., A Comparison of Methamphetamine-Induced Psychosis and Schizophrenia: A Review of Positive, Negative, and Cognitive Symptomatology, Frontiers in Psychiatry, 9, 2018. Crossref

  353. Battal Merlet Lâle, Blanchet Alain, Lockman Hazlin, Kostova Milena, An Event Related Potentials Study of Semantic Coherence Effect during Episodic Encoding in Schizophrenia Patients, Schizophrenia Research and Treatment, 2018, 2018. Crossref

  354. Brickman Adam M., Buchsbaum Monte S., Bloom Rachel, Bokhoven Pauline, Paul-Odouard Reshmi, Haznedar M Mehmet, Dahlman Karen L., Hazlett Erin A., Aronowitz Jonathan, Heath Desmond, Shihabuddin Lina, Neuropsychological Functioning in First-Break, Never-Medicated Adolescents With Psychosis, Journal of Nervous & Mental Disease, 192, 9, 2004. Crossref

  355. Lipina Tatiana V., Beregovoy Nikolay A., Tkachenko Alina A., Petrova Ekaterina S., Starostina Marina V., Zhou Qiang, Li Shupeng, Uncoupling DISC1 × D2R Protein-Protein Interactions Facilitates Latent Inhibition in Disc1-L100P Animal Model of Schizophrenia and Enhances Synaptic Plasticity via D2 Receptors, Frontiers in Synaptic Neuroscience, 10, 2018. Crossref

  356. Ammari Narmeen, Heinrichs R. Walter, Miles Ashley A., An investigation of 3 neurocognitive subtypes in schizophrenia, Schizophrenia Research, 121, 1-3, 2010. Crossref

  357. Leggio G. M., Torrisi S. A., Mastrogiacomo R., Mauro D., Chisari M., Devroye C., Scheggia D., Nigro M., Geraci F., Pintori N., Giurdanella G., Costa L., Bucolo C., Ferretti V., Sortino M. A., Ciranna L., De Luca M. A., Mereu M., Managò F., Salomone S., Drago F., Papaleo F., The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans, Molecular Psychiatry, 26, 4, 2021. Crossref

  358. Chidambaram Saravana Babu, Rathipriya A.G., Bolla Srinivasa Rao, Bhat Abid, Ray Bipul, Mahalakshmi Arehally Marappa, Manivasagam Thamilarasan, Thenmozhi Arokiasamy Justin, Essa Musthafa Mohamed, Guillemin Gilles J., Chandra Ramesh, Sakharkar Meena Kishore, Dendritic spines: Revisiting the physiological role, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 92, 2019. Crossref

  359. Rodionov G. I., Luschekina E. A., Kudryashov P. N., Strelets V. B., Neurophysiological Features of Perception of Roman and Arabic Numerals in Paranoid Schizophrenia Patients, Human Physiology, 45, 5, 2019. Crossref

  360. Jindal Ripu D., Pillai Anil K., Mahadik Sahebrao P., Eklund Kevin, Montrose Debra M., Keshavan Matcheri S., Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia, Schizophrenia Research, 119, 1-3, 2010. Crossref

  361. Piras F., Piras F., Banaj N., Ciullo V., Vecchio D., Edden R. A. E., Spalletta G., Cerebellar GABAergic correlates of cognition‐mediated verbal fluency in physiology and schizophrenia, Acta Psychiatrica Scandinavica, 139, 6, 2019. Crossref

  362. Kottaram Akhil, Johnston Leigh A., Cocchi Luca, Ganella Eleni P., Everall Ian, Pantelis Christos, Kotagiri Ramamohanarao, Zalesky Andrew, Brain network dynamics in schizophrenia: Reduced dynamism of the default mode network, Human Brain Mapping, 40, 7, 2019. Crossref

  363. Krajcovic Branislav, Fajnerova Iveta, Horacek Jiri, Kelemen Eduard, Kubik Stepan, Svoboda Jan, Stuchlik Ales, Neural and neuronal discoordination in schizophrenia: From ensembles through networks to symptoms, Acta Physiologica, 226, 4, 2019. Crossref

  364. Zhang Zhang-Jin, Kang Wan-Hu, Li Qiang, Wang Xue-Yi, Yao Shao-Min, Ma Ai-Qun, Beneficial effects of ondansetron as an adjunct to haloperidol for chronic, treatment-resistant schizophrenia: A double-blind, randomized, placebo-controlled study, Schizophrenia Research, 88, 1-3, 2006. Crossref

  365. Xia Zongqi, Roth Bryan L., Novel Mechanisms of Drug Treatment in Psychiatry, in The Medical Basis of Psychiatry, 2008. Crossref

  366. Palmer Barton W., Savla Gauri N., Fellows Ian E., Twamley Elizabeth W., Jeste Dilip V., Lacro Jonathan P., Do people with schizophrenia have differential impairment in episodic memory and/or working memory relative to other cognitive abilities?, Schizophrenia Research, 116, 2-3, 2010. Crossref

  367. Tian Yang, Liu Dianying, Wang Dongmei, Wang Jiesi, Xu Hang, Dai Qilong, Andriescue Elena C., Wu Hanjing E., Xiu Meihong, Chen Dachun, Wang Li, Chen Yiwen, Yang Ruilang, Wu Anshi, Wei Chang Wei, Zhang Xiangyang, Obesity in Chinese patients with chronic schizophrenia: Prevalence, clinical correlates and relationship with cognitive deficits, Schizophrenia Research, 215, 2020. Crossref

  368. Tanaka Shoji, Stable and Unstable Activation of the Prefrontal Cortex with Dopaminergic Modulation, in Monoaminergic Modulation of Cortical Excitability, 2007. Crossref

  369. Hashimoto Kenji, Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical Findings, Current Psychiatry Reports, 21, 8, 2019. Crossref

  370. Reynolds Nicky, Scragg Peter, Compliance with command hallucinations: the role of power in relation to the voice, and social rank in relation to the voice and others, Journal of Forensic Psychiatry & Psychology, 21, 1, 2010. Crossref

  371. Takakuwa Misae, Watanabe Yumi, Tanaka Kiichi, Ishii Taketoshi, Kagaya Kenta, Taniguchi Hiroyuki, Kotera Jun, Hashimoto Kenji, Antipsychotic-like effects of a novel phosphodiesterase 10A inhibitor T-251 in rodents, Pharmacology Biochemistry and Behavior, 185, 2019. Crossref

  372. González-Blanch César, Rodríguez-Sánchez José Manuel, Pérez-Iglesias Rocío, Pardo-García Gema, Martínez-García Obdulia, Vázquez-Barquero José Luis, Crespo-Facorro Benedicto, First-episode schizophrenia patients neuropsychologically within the normal limits: Evidence of deterioration in speed of processing, Schizophrenia Research, 119, 1-3, 2010. Crossref

  373. Wu Dongsheng, Lv Peilin, Li Fei, Zhang Wenjing, Fu Gui, Dai Jing, Hu Na, Liu Jieke, Xiao Yuan, Li Siyi, Shah Chandan, Tao Bo, Zhao Youjin, Gong Qiyong, Lui Su, Association of peripheral cytokine levels with cerebral structural abnormalities in schizophrenia, Brain Research, 1724, 2019. Crossref

  374. Carrión R. E., McLaughlin D., Auther A. M., Olsen R., Correll C. U., Cornblatt B. A., The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis, Psychological Medicine, 45, 15, 2015. Crossref

  375. Zugno Alexandra I., Matos Maria Paula, Canever Leila, Fraga Daiane B., De Luca Renata D., Ghedim Fernando V., Deroza Pedro F., de Oliveira Mariana B., Pacheco Felipe D., Valvassori Samira S., Volpato Ana Maria, Budni Josiane, Quevedo João, Evaluation of acetylcholinesterase activity and behavioural alterations induced by ketamine in an animal model of schizophrenia, Acta Neuropsychiatrica, 26, 1, 2014. Crossref

  376. Chang W. C., Hui C. L. M., Tang J. Y. M., Wong G. H. Y., Chan S. K. W., Lee E. H. M., Chen E. Y. H., Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study, Psychological Medicine, 43, 9, 2013. Crossref

  377. Krieger Stephan, Lis Stefanie, Meyer-Lindenberg Andreas, Neuropsychologische Aspekte der Therapie mit Psychopharmaka, in Neuropsychologie psychischer Störungen, 2004. Crossref

  378. Li Zezhi, Liu Lihua, Lin Wei, Zhou Yongjie, Zhang Guangya, Du Xiangdong, Li Yi, Tang Wei, Zhang Xiangyang, NRG3 contributes to cognitive deficits in chronic patients with schizophrenia, Schizophrenia Research, 215, 2020. Crossref

  379. Wölwer Wolfgang, Brinkmeyer J., Frommann N., Riesbeck M., Wagner M., Gaebel W., Kognitive Beeinträchtigungen bei schizophrenen Ersterkrankungen im Vergleich zu psychosenahen Fällen und mehrfach Erkrankten, in Schizophrenie — Zukunftsperspektiven in Klinik und Forschung, 2010. Crossref

  380. Alexander Peter D., Gicas Kristina M., Cheng Alex, Lang Donna J., Procyshyn Ric M., Vertinsky Alexandra T., Panenka William J., Thornton Allen E., Rauscher Alexander, Wong Jamie Y. X., Chan Tasha, Jones Andrea A., Vila-Rodriguez F., Honer William G., Barr Alasdair M., A comparison of regional brain volumes and white matter connectivity in subjects with stimulant induced psychosis versus schizophrenia, Psychopharmacology, 236, 12, 2019. Crossref

  381. Xiong Yan-Bing, Bo Qi-Jing, Wang Chang-Ming, Tian Qing, Liu Yi, Wang Chuan-Yue, Differential of Frequency and Duration Mismatch Negativity and Theta Power Deficits in First-Episode and Chronic Schizophrenia, Frontiers in Behavioral Neuroscience, 13, 2019. Crossref

  382. Wong Albert, Feldcamp Laura, Biomarkers in Schizophrenia, in Biomarkers for Psychiatric Disorders, 2008. Crossref

  383. Shao Zhicheng, Noh Haneul, Bin Kim Woong, Ni Peiyan, Nguyen Christine, Cote Sarah E., Noyes Elizabeth, Zhao Joyce, Parsons Teagan, Park James M., Zheng Kelvin, Park Joshua J., Coyle Joseph T., Weinberger Daniel R., Straub Richard E., Berman Karen F., Apud Jose, Ongur Dost, Cohen Bruce M., McPhie Donna L., Rapoport Judith L., Perlis Roy H., Lanz Thomas A., Xi Hualin Simon, Yin Changhong, Huang Weihua, Hirayama Teruyoshi, Fukuda Emi, Yagi Takeshi, Ghosh Sulagna, Eggan Kevin C., Kim Hae-Young, Eisenberg Leonard M., Moghadam Alexander A., Stanton Patric K., Cho Jun-Hyeong, Chung Sangmi, Dysregulated protocadherin-pathway activity as an intrinsic defect in induced pluripotent stem cell–derived cortical interneurons from subjects with schizophrenia, Nature Neuroscience, 22, 2, 2019. Crossref

  384. Vreeker A., Boks M. P. M., Abramovic L., Verkooijen S., van Bergen A. H., Hillegers M. H. J., Spijker A. T., Hoencamp E., Regeer E. J., Riemersma-Van der Lek R. F., Stevens A. W. M. M., Schulte P. F. J., Vonk R., Hoekstra R., van Beveren N. J. M., Kupka R. W., Brouwer R. M., Bearden C. E., MacCabe J. H., Ophoff R. A., High educational performance is a distinctive feature of bipolar disorder: a study on cognition in bipolar disorder, schizophrenia patients, relatives and controls, Psychological Medicine, 46, 4, 2016. Crossref

  385. Talbot K., Ong W.- Y., Blake D. J., Tang J., Louneva N., Carlson G. C., Arnold S. E., Dysbindin-1 and Its Protein Family, in Handbook of Neurochemistry and Molecular Neurobiology, 2009. Crossref

  386. Stochl Jan, Whittier Anjalene, Wagner Adam P., Veijola Juha, Jääskeläinen Erika, Miettunen Jouko, Khandaker Golam M., Jones Peter B., Association between developmental milestones and age of schizophrenia onset: Results from the Northern Finland Birth Cohort 1966, Schizophrenia Research, 208, 2019. Crossref

  387. Andorko Nicole D., Rakhshan-Rouhakhtar Pamela, Hinkle Caroline, Mittal Vijay A., McAllister Maureen, DeVylder Jordan, Schiffman Jason, Assessing validity of retrospective recall of physical activity in individuals with psychosis-like experiences, Psychiatry Research, 273, 2019. Crossref

  388. Meisenzahl E. M., Möller H. -J., Bildgebende Verfahren in der Schizophrenieforschung, in Aktuelle Aspekte der Pathogenese und Therapie der Schizophrenie, 2006. Crossref

  389. Goudsmit Nora, Wolitzky Rachel, Seckinger Regine Anna, Corcoran Cheryl, Stanford Arielle, Rosenfield Paul, Goetz Ray, Malaspina Dolores, Trail Making and Olfaction in Schizophrenia: Implications for Processing Speed, CNS Spectrums, 9, 5, 2004. Crossref

  390. Iliadou Vasiliki (Vivian), Apalla Kalliopi, Kaprinis Stergios, Nimatoudis Ioannis, Kaprinis George, Iacovides Apostolos, Is Central Auditory Processing Disorder Present in Psychosis?, American Journal of Audiology, 22, 2, 2013. Crossref

  391. Zhang Wei, Cai Suping, Huang Kexin, Lv Yahui, Kang Yafei, Wang Qiang, Huang Liyu, Association between schizophrenia risk allele dosage of rs6994992 and whole-brain structural and functional characteristics, Psychiatry Research: Neuroimaging, 294, 2019. Crossref

  392. Park Jeong Ha, Hong Ji Son, Kim Sun Mi, Min Kyung Joon, Chung Un Sun, Han Doug Hyun, Effects of Amisulpride Adjunctive Therapy on Working Memory and Brain Metabolism in the Frontal Cortex of Patients with Schizophrenia: A Preliminary Positron Emission Tomography/Computerized Tomography Investigation, Clinical Psychopharmacology and Neuroscience, 17, 2, 2019. Crossref

  393. Gooding Diane C., Braun Jacqueline G., Studer Jessica A., Attentional network task performance in patients with schizophrenia–spectrum disorders: Evidence of a specific deficit, Schizophrenia Research, 88, 1-3, 2006. Crossref

  394. Nakajima Miho, Schmitt L. Ian, Understanding the circuit basis of cognitive functions using mouse models, Neuroscience Research, 152, 2020. Crossref

  395. Hermens Daniel F, Lubman Dan I, Ward Philip B, Naismith Sharon L, Hickie Ian B, Amphetamine psychosis: a model for studying the onset and course of psychosis, Medical Journal of Australia, 190, S4, 2009. Crossref

  396. Chianetta Jean-Marc, Lefebvre Mylène, LeBlanc Renée, Grignon Sylvain, Comparative psychometric properties of the BACS and RBANS in patients with schizophrenia and schizoaffective disorder, Schizophrenia Research, 105, 1-3, 2008. Crossref

  397. Cuesta Manuel J., Peralta Victor, Zarzuela Amalia, Empirical validation of competing definitions of schizophrenia, Schizophrenia Research, 95, 1-3, 2007. Crossref

  398. Tanzer Timothy, Shah Shelukumar, Benson Catherine, De Monte Veronica, Gore-Jones Victoria, Rossell Susan L., Dark Frances, Kisely Steve, Siskind Dan, Melo Catarina Drumonde, Varenicline for cognitive impairment in people with schizophrenia: systematic review and meta-analysis, Psychopharmacology, 237, 1, 2020. Crossref

  399. van Scheltinga A. F. Terwisscha, Bakker S. C., van Haren N. E. M., Derks E. M., Buizer-Voskamp J. E., Cahn W., Ripke S., Ophoff R. A., Kahn R. S., Schizophrenia genetic variants are not associated with intelligence, Psychological Medicine, 43, 12, 2013. Crossref

  400. Joshua Nicole, Gogos Andrea, Rossell Susan, Executive functioning in schizophrenia: A thorough examination of performance on the Hayling Sentence Completion Test compared to psychiatric and non-psychiatric controls, Schizophrenia Research, 114, 1-3, 2009. Crossref

  401. Jing Rixing, Li Peng, Ding Zengbo, Lin Xiao, Zhao Rongjiang, Shi Le, Yan Hao, Liao Jinmin, Zhuo Chuanjun, Lu Lin, Fan Yong, Machine learning identifies unaffected first‐degree relatives with functional network patterns and cognitive impairment similar to those of schizophrenia patients, Human Brain Mapping, 2019. Crossref

  402. Volk David W., Lewis David A., Prefrontal Cortical Circuits in Schizophrenia, in Behavioral Neurobiology of Schizophrenia and Its Treatment, 4, 2010. Crossref

  403. van Raalten Tamar R., Ramsey Nick F., Jansma J. Martijn, Jager Gerry, Kahn René S., Automatization and working memory capacity in schizophrenia, Schizophrenia Research, 100, 1-3, 2008. Crossref

  404. Gigg John, McEwan Francesca, Smausz Rebecca, Neill Joanna, Harte Michael K, Synaptic biomarker reduction and impaired cognition in the sub-chronic PCP mouse model for schizophrenia, Journal of Psychopharmacology, 34, 1, 2020. Crossref

  405. Rüsch Nicolas, Spoletini Ilaria, Wilke Marko, Bria Pietro, Di Paola Margherita, Di Iulio Fulvia, Martinotti Giovanni, Caltagirone Carlo, Spalletta Gianfranco, Prefrontal–thalamic–cerebellar gray matter networks and executive functioning in schizophrenia, Schizophrenia Research, 93, 1-3, 2007. Crossref

  406. Brill N., Reichenberg A., Rabinowitz J., Harary E., Lubin G., Davidson M., Weiser M., Accuracy of self-reported premorbid functioning in schizophrenia, Schizophrenia Research, 97, 1-3, 2007. Crossref

  407. Rodríguez Pulido Francisco, Caballero Estebaranz Nayra, González Dávila Enrique, Melián Cartaya Maria Jesús, Cognitive remediation to improve the vocational outcomes of people with severe mental illness, Neuropsychological Rehabilitation, 31, 2, 2021. Crossref

  408. Morè Lorenzo, Lauterborn Julie C., Papaleo Francesco, Brambilla Riccardo, Enhancing cognition through pharmacological and environmental interventions: Examples from preclinical models of neurodevelopmental disorders, Neuroscience & Biobehavioral Reviews, 110, 2020. Crossref

  409. Кутепов Илья, Kutepov Ilya, Крысько Вадим, Krysko Vadim, Крысько Антон, Krysko Anton, Павлов Сергей, Pavlov Sergey, Жигалов Максим, Zhigalov Maxim, Папкова Ирина, Papkova Irina, Салтыкова Ольга, Saltykova Olga, Ярошенко Татьяна, Yaroshenko Tatyana, Крылова Екатерина, Krylova Ekaterina, Яковлева Татьяна, Yakovleva Tat'yana, Добриян Виталий, Dobriyan Vitaly, Ерофеев Николай, Erofeev Nikolay, Complexity of EEG Signals in Schizophrenia Syndromes, GraphiCon'2019 Proceedings. Volume 2, 2019. Crossref

  410. Gogos Joseph A., Karayiorgou Maria, Genetic Mouse Models of Psychiatric Disorders, in Transgenic and Knockout Models of Neuropsychiatric Disorders, 2006. Crossref

  411. Andric Petrovic Sanja, Jerotic Stefan, Mihaljevic Marina, Pavlovic Zorana, Ristic Ivan, Soldatovic Ivan, Maric Nadja P., Sex differences in facial emotion recognition in health and psychotic disorders, Cognitive Neuropsychiatry, 24, 2, 2019. Crossref

  412. Melchitzky Darlene S., Lewis David A., Development of thalamocortical circuitry and the pathophysiology of schizophrenia, in Neurodevelopment and Schizophrenia, 2004. Crossref

  413. Keshavan Matcheri S., Cornblatt Barbara A., Developmental models and hypothesis-driven early interventions in schizophrenia, in Neurodevelopment and Schizophrenia, 2004. Crossref

  414. Phenis David, Vunck Sarah A., Valentini Valentina, Arias Hugo, Schwarcz Robert, Bruno John P., Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task, Psychopharmacology, 237, 6, 2020. Crossref

  415. Hafiz Pegah, Bardram Jakob Eyvind, The Ubiquitous Cognitive Assessment Tool for Smartwatches: Design, Implementation, and Evaluation Study, JMIR mHealth and uHealth, 8, 6, 2020. Crossref

  416. Wang San-Ping, Wang Jung-Der, Chang Jer-Hao, Wu Bo-Jian, Wang Tso-Jen, Sun Hsiao-Ju, Symptomatic remission affects employment outcomes in schizophrenia patients, BMC Psychiatry, 20, 1, 2020. Crossref

  417. Broderick Charles, Azizian Allen, Warburton Katherine, Length of stay for inpatient incompetent to stand trial patients: importance of clinical and demographic variables, CNS Spectrums, 25, 5, 2020. Crossref

  418. LOBELLOVÁ V., BRICHTOVÁ E., PETRÁSEK T., VALEŠ K., STUCHLÍK A., Higher Doses of (+)MK-801 (Dizocilpine) Induced Mortality and Procedural but Not Cognitive Deficits in Delayed Testing in the Active Place Avoidance With Reversal on the Carousel, Physiological Research, 2015. Crossref

  419. Hua Lingling, Grent-t’-Jong Tineke, Uhlhaas Peter J., Magnetoencephalographical Research in Schizophrenia: Current Status and Perspectives, in Neuroimaging in Schizophrenia, 2020. Crossref

  420. de Boer J. N., van Hoogdalem M., Mandl R. C. W., Brummelman J., Voppel A. E., Begemann M. J. H., van Dellen E., Wijnen F. N. K., Sommer I. E. C., Language in schizophrenia: relation with diagnosis, symptomatology and white matter tracts, npj Schizophrenia, 6, 1, 2020. Crossref

  421. Ibi Daisuke, Nakasai Genki, Koide Nayu, Sawahata Masahito, Kohno Takao, Takaba Rika, Nagai Taku, Hattori Mitsuharu, Nabeshima Toshitaka, Yamada Kiyofumi, Hiramatsu Masayuki, Reelin Supplementation Into the Hippocampus Rescues Abnormal Behavior in a Mouse Model of Neurodevelopmental Disorders, Frontiers in Cellular Neuroscience, 14, 2020. Crossref

  422. Ji Xiaoyu, Quan Wenxiang, Yang Lei, Chen Juan, Wang Jiuju, Wu Tongning, Classification of Schizophrenia by Seed-based Functional Connectivity using Prefronto-Temporal Functional Near Infrared Spectroscopy, Journal of Neuroscience Methods, 344, 2020. Crossref

  423. Guimond Synthia, Sandoval Luis, Keshavan Matcheri S., Schizophrenia, in Cognitive Rehabilitation and Neuroimaging, 2020. Crossref

  424. Hokkanen Laura, Barbosa Fernando, Ponchel Amélie, Constantinou Marios, Kosmidis Mary H., Varako Nataliya, Kasten Erich, Mondini Sara, Lettner Sandra, Baker Gus, Persson Bengt A., Hessen Erik, Clinical Neuropsychology as a Specialist Profession in European Health Care: Developing a Benchmark for Training Standards and Competencies Using the Europsy Model?, Frontiers in Psychology, 11, 2020. Crossref

  425. Nikiforuk Agnieszka, The procognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia, Reviews in the Neurosciences, 25, 3, 2014. Crossref

  426. Naujock Maximilian, Speidel Anna, Fischer Sandra, Kizner Valeria, Dorner-Ciossek Cornelia, Gillardon Frank, Neuronal Differentiation of Induced Pluripotent Stem Cells from Schizophrenia Patients in Two-Dimensional and in Three-Dimensional Cultures Reveals Increased Expression of the Kv4.2 Subunit DPP6 That Contributes to Decreased Neuronal Activity, Stem Cells and Development, 29, 24, 2020. Crossref

  427. Yang Jiayi, Ji Xiaoyu, Quan Wenxiang, Liu Yunshan, Wei Bowen, Wu Tongning, Classification of Schizophrenia by Functional Connectivity Strength Using Functional Near Infrared Spectroscopy, Frontiers in Neuroinformatics, 14, 2020. Crossref

  428. Yazıhan Naksidil Torun, Yetkin Sinan, Sleep, sleep spindles, and cognitive functions in drug-naive patients with first-episode psychosis, Journal of Clinical Sleep Medicine, 16, 12, 2020. Crossref

  429. Li Shen, Chen Dachun, Xiu Meihong, Li Jie, Zhang Xiang Yang, Diabetes mellitus, cognitive deficits and serum BDNF levels in chronic patients with schizophrenia: A case-control study, Journal of Psychiatric Research, 134, 2021. Crossref

  430. Lewine Richard, Hart Mara, Schizophrenia spectrum and other psychotic disorders, in Sex Differences in Neurology and Psychiatry, 175, 2020. Crossref

  431. Takao Keizo, Toyama Keiko, Nakanishi Kazuo, Hattori Satoko, Takamura Hironori, Takeda Masatoshi, Miyakawa Tsuyoshi, Hashimoto Ryota, Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia, Molecular Brain, 1, 1, 2008. Crossref

  432. Streel Emmanuel, Chinet Léonie, Bibliographie, in Cannabis, 2008. Crossref

  433. Spiros Athan, Geerts Hugo, Toward Predicting Impact of Common Genetic Variants on Schizophrenia Clinical Responses With Antipsychotics: A Quantitative System Pharmacology Study, Frontiers in Neuroscience, 15, 2021. Crossref

  434. Cao Xianyu, Huang Huan, Zhang Bei, Jiang Yuchao, He Hui, Duan Mingjun, Jiang Sisi, Tan Ying, Yao Dezhong, Li Chao, Luo Cheng, Surface-Based Spontaneous Oscillation in Schizophrenia: A Resting-State Functional Magnetic Resonance Imaging Study, Frontiers in Human Neuroscience, 15, 2021. Crossref

  435. Goodman Craig, Finkel Boris, Naser Mahmud, Andreyev Piter, Segev Yehoshua, Kurs Rena, Melamed Yuval, Bleich Avi, Neurocognitive Deterioration in Elderly Chronic Schizophrenia Patients With and Without PTSD, Journal of Nervous & Mental Disease, 195, 5, 2007. Crossref

  436. Speers Lucinda J., Bilkey David K., Disorganization of Oscillatory Activity in Animal Models of Schizophrenia, Frontiers in Neural Circuits, 15, 2021. Crossref

  437. Christensen D. S., Flensborg-Madsen T., Andersen N. E., Rosenkær I. B., Mortensen E. L., Personality and risk of hospital diagnosed mental disorder: a 35 years’ prospective study, Social Psychiatry and Psychiatric Epidemiology, 56, 11, 2021. Crossref

  438. Zhang Jiuping, Cheng Xin, Zhang Huihui, Xu Ping, Jin Peiying, Ke Xiaoyan, Analysis of the status of drug treatment in 746 inpatients with early-onset schizophrenia in China: a retrospective study, BMC Psychiatry, 21, 1, 2021. Crossref

  439. Geerts Hugo, Roberts Patrick, Spiros Athan, Exploring the relation between BOLD fMRI and cognitive performance using a computer-based quantitative systems pharmacology model: Applications to the COMTVAL158MET genotype and ketamine, European Neuropsychopharmacology, 50, 2021. Crossref

  440. Cao Hengyi, Zhou Hang, Cannon Tyrone D., Functional connectome-wide associations of schizophrenia polygenic risk, Molecular Psychiatry, 26, 6, 2021. Crossref

  441. Bowins Brad, Human-specific cognition, in States and Processes for Mental Health, 2021. Crossref

  442. Jo Young Tak, Joo Yeon Ho, Changes in the DSM Diagnostic Concept of Schizophrenia: From 1980 to 2013, Journal of Korean Neuropsychiatric Association, 60, 4, 2021. Crossref

  443. Umemori Juzoh, Takao Keizo, Koshimizu Hisatsugu, Hattori Satoko, Furuse Tamio, Wakana Shigeharu, Miyakawa Tsuyoshi, ENU-mutagenesis mice with a non-synonymous mutation in Grin1 exhibit abnormal anxiety-like behaviors, impaired fear memory, and decreased acoustic startle response, BMC Research Notes, 6, 1, 2013. Crossref

  444. Suh Junghyup, Foster David J., Davoudi Heydar, Wilson Matthew A., Tonegawa Susumu, Impaired Hippocampal Ripple-Associated Replay in a Mouse Model of Schizophrenia, Neuron, 80, 2, 2013. Crossref

  445. Landreth K., Simanaviciute U., Fletcher J., Grayson B., Grant R. A., Harte M. H., Gigg J., Dissociating the effects of distraction and proactive interference on object memory through tests of novelty preference, Brain and Neuroscience Advances, 5, 2021. Crossref

  446. Välimäki Maritta, Yang Min, Lam Yuen Ting Joyce, Lantta Tella, Palva Matias, Palva Satu, Yee Benjamin, Yip Siu Hung, Yu Kin-sun Dan, Chang Hing Chiu Charles, Cheng Po Yee Ivy, Bressington Daniel, The impact of video gaming on cognitive functioning of people with schizophrenia (GAME-S): study protocol of a randomised controlled trial, BMC Psychiatry, 21, 1, 2021. Crossref

  447. Miranda Lucas, Paul Riya, Pütz Benno, Koutsouleris Nikolaos, Müller-Myhsok Bertram, Systematic Review of Functional MRI Applications for Psychiatric Disease Subtyping, Frontiers in Psychiatry, 12, 2021. Crossref

  448. Ni Peiyan, Liu Manli, Wang Dequan, Tian Yang, Zhao Liansheng, Wei Jinxue, Yu Xueli, Qi Xueyu, Li Xiaojing, Yu Hua, Ni Rongjun, Ma Xiaohong, Deng Wei, Guo Wanjun, Wang Qiang, Li Tao, Association Analysis Between Catechol-O-Methyltransferase Expression and Cognitive Function in Patients with Schizophrenia, Bipolar Disorder, or Major Depression, Neuropsychiatric Disease and Treatment, Volume 17, 2021. Crossref

  449. Chang Chia-Yuan, Luo Da-Zhong, Pei Ju-Chun, Kuo Ming-Che, Hsieh Yi-Chen, Lai Wen-Sung, Not Just a Bystander: The Emerging Role of Astrocytes and Research Tools in Studying Cognitive Dysfunctions in Schizophrenia, International Journal of Molecular Sciences, 22, 10, 2021. Crossref

  450. Ciampoli Mariasole, Scheggia Diego, Papaleo Francesco, Automatic Intra-/Extra-Dimensional Attentional Set-Shifting Task in Adolescent Mice, Frontiers in Behavioral Neuroscience, 15, 2021. Crossref

  451. López Abraham, Mendieta Laura, Prades Roger, Royo Soledad, Tarragó Teresa, Giralt Ernest, Peptide POP inhibitors for the treatment of the cognitive symptoms of schizophrenia, Future Medicinal Chemistry, 5, 13, 2013. Crossref

  452. Ablordeppey Seth, Ofori Edward, Antipsychotic Agents, in Burger's Medicinal Chemistry and Drug Discovery, 2021. Crossref

  453. Datta Dibyadeep, Arnsten Amy F.T., Unique Molecular Regulation of Higher-Order Prefrontal Cortical Circuits: Insights into the Neurobiology of Schizophrenia, ACS Chemical Neuroscience, 9, 9, 2018. Crossref

  454. Abdul Rashid Nur Amirah, Martanto Wijaya, Yang Zixu, Wang Xuancong, Heaukulani Creighton, Vouk Nikola, Buddhika Thisum, Wei Yuan, Verma Swapna, Tang Charmaine, Morris Robert J T, Lee Jimmy, Evaluating the utility of digital phenotyping to predict health outcomes in schizophrenia: protocol for the HOPE-S observational study, BMJ Open, 11, 10, 2021. Crossref

  455. Antonova Ingrida, van Swam Claudia, Hubl Daniela, Griskova-Bulanova Inga, Dierks Thomas, Koenig Thomas, Altered Visuospatial Processing in Schizophrenia: An Event-related Potential Microstate Analysis Comparing Patients with and without Hallucinations with Healthy Controls, Neuroscience, 479, 2021. Crossref

  456. Cahoon Elizabeth Khaykin, McGinty Emma E, Ford Daniel E, Daumit Gail L, Schizophrenia and potentially preventable hospitalizations in the United States: a retrospective cross-sectional study, BMC Psychiatry, 13, 1, 2013. Crossref

  457. Vafadari Behnam, Stress and the Role of the Gut–Brain Axis in the Pathogenesis of Schizophrenia: A Literature Review, International Journal of Molecular Sciences, 22, 18, 2021. Crossref

  458. Gomes Felipe V., Grace Anthony A., Beyond Dopamine Receptor Antagonism: New Targets for Schizophrenia Treatment and Prevention, International Journal of Molecular Sciences, 22, 9, 2021. Crossref

  459. Prokudina O. I., Alekhina T. A., Effect of D-serine on Anxiety-like Behavior and Spatial Learning Ability in GC Rats Selected for the Predisposition to Catatonic Reactions, Journal of Evolutionary Biochemistry and Physiology, 57, 6, 2021. Crossref

  460. Stogios Nicolette, Gdanski Alexander, Gerretsen Philip, Chintoh Araba F., Graff-Guerrero Ariel, Rajji Tarek K., Remington Gary, Hahn Margaret K., Agarwal Sri Mahavir, Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health, npj Schizophrenia, 7, 1, 2021. Crossref

  461. Shoeibi Afshin, Sadeghi Delaram, Moridian Parisa, Ghassemi Navid, Heras Jónathan, Alizadehsani Roohallah, Khadem Ali, Kong Yinan, Nahavandi Saeid, Zhang Yu-Dong, Gorriz Juan Manuel, Automatic Diagnosis of Schizophrenia in EEG Signals Using CNN-LSTM Models, Frontiers in Neuroinformatics, 15, 2021. Crossref

  462. Velthorst Eva, Mollon Josephine, Murray Robin M., de Haan Lieuwe, Germeys Inez Myin, Glahn David C., Arango Celso, van der Ven Els, Di Forti Marta, Bernardo Miguel, Guloksuz Sinan, Delespaul Philippe, Mezquida Gisela, Amoretti Silvia, Bobes Julio, Saiz Pilar A., García-Portilla María Paz, Santos José Luis, Jiménez-López Estela, Sanjuan Julio, Aguilar Eduardo J., Arrojo Manuel, Carracedo Angel, López Gonzalo, González-Peñas Javier, Parellada Mara, Atbaşoğlu Cem, Saka Meram Can, Üçok Alp, Alptekin Köksal, Akdede Berna, Binbay Tolga, Altınyazar Vesile, Ulaş Halis, Yalınçetin Berna, Gümüş-Akay Güvem, Beyaz Burçin Cihan, Soygür Haldun, Cankurtaran Eylem Şahin, Kaymak Semra Ulusoy, Maric Nadja P., Mihaljevic Marina M., Petrovic Sanja Andric, Mirjanic Tijana, Del-Ben Cristina Marta, Ferraro Laura, Gayer-Anderson Charlotte, Jones Peter B., Jongsma Hannah E., Kirkbride James B., La Cascia Caterina, Lasalvia Antonio, Tosato Sarah, Llorca Pierre-Michel, Menezes Paulo Rossi, Morgan Craig, Quattrone Diego, Menchetti Marco, Selten Jean-Paul, Szöke Andrei, Tarricone Ilaria, Tortelli Andrea, McGuire Philip, Valmaggia Lucia, Kempton Matthew J., van der Gaag Mark, Riecher-Rössler Anita, Bressan Rodrigo A., Barrantes-Vidal Neus, Nelson Barnaby, McGorry Patrick, Pantelis Chris, Krebs Marie-Odile, Ruhrmann Stephan, Sachs Gabriele, Rutten Bart P. F., van Os Jim, Alizadeh Behrooz Z., van Amelsvoort Therese, Bartels-Velthuis Agna A., Bruggeman Richard, van Beveren Nico J., Luykx Jurjen J., Cahn Wiepke, Simons Claudia J. P., Kahn Rene S., Schirmbeck Frederike, van Winkel Ruud, Calem Maria, Tognin Stefania, Modinos Gemma, Pisani Sara, Kraan Tamar C., van Dam Daniella S., Burger Nadine, Amminger G. Paul, Politis Athena, Goodall Joanne, Borgwardt Stefan, Studerus Erich, Gadelha Ary, Brietzke Elisa, Asevedo Graccielle, Asevedo Elson, Zugman Andre, Domínguez-Martínez Tecelli, Monsonet Manel, Cristóbal-Narváez Paula, Racioppi Anna, Kwapil Thomas R., Kazes Mathilde, Daban Claire, Bourgin Julie, Gay Olivier, Mam-Lam-Fook Célia, Nordholm Dorte, Rander Lasse, Krakauer Kristine, Glenthøj Louise Birkedal, Glenthøj Birte, Gebhard Dominika, Arnhold Julia, Klosterkötter Joachim, Lasser Iris, Winklbaur Bernadette, Reichenberg Abraham, Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings, Molecular Psychiatry, 26, 8, 2021. Crossref

  463. Abi-Dargham Anissa, Javitch Jonathan A, Slifstein Mark, Anticevic Alan, Calkins Monica E, Cho Youngsun T, Fonteneau Clara, Gil Roberto, Girgis Ragy, Gur Raquel E, Gur Ruben C, Grinband Jack, Kantrowitz Joshua, Kohler Christian, Krystal John, Murray John, Ranganathan Mohini, Santamauro Nicole, Van Snellenberg Jared, Tamayo Zailyn, Wolf Daniel, D’Souza Deepak, Srihari Vinod, Gueorguieva Ralitza, Patel Prashant, Forselius-Bielen Kimberlee, Lu Jing, Butler Audrey, Fram Geena, Afriyie-Agyemang Yvette, Selloni Alexandria, Cadavid Laura, Gomez-Luna Sandra, Gupta Aarti, Radhakrishnan Rajiv, Rashid Ali, Aker Ryan, Abrahim Philisha, Bassir Nia Anahita, Surti Toral, Kegeles Lawrence S, Carlson Marlene, Goldberg Terry, Gangwisch James, Benedict Erinne, Govil Preetika, Brazis Stephanie, Mayer Megan, de la Garrigue Nathalie, Fallon Natalka, Baumvoll Topaz, Abeykoon Sameera, Perlman Greg, Bobchin Kelly, Elliott Mark, Schmidt Lyndsay, Rush Sage, Port Allison, Heffernan Zac, Laney Nina, Kantor Jenna, Hohing Thomas, Gray David, Lieberman Jeffrey, Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia, Schizophrenia Bulletin, 48, 1, 2022. Crossref

  464. Flinkkilä Eerika, Keski-Rahkonen Anna, Marttunen Mauri, Raevuori Anu, Prenatal Inflammation, Infections and Mental Disorders, Psychopathology, 49, 5, 2016. Crossref

  465. Yang Jiaxin, Yang Xiong, Tang Ke, Interneuron development and dysfunction, The FEBS Journal, 289, 8, 2022. Crossref

  466. Egashira Nobuaki, Ishigami Noriko, Mishima Kenichi, Iwasaki Katsunori, Oishi Ryozo, Fujiwara Michihiro, Δ9-Tetrahydrocannabinol-induced cognitive deficits are reversed by olanzapine but not haloperidol in rats, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32, 2, 2008. Crossref

  467. Ma Min, Ren Qian, Yang Jun, Zhang Kai, Xiong Zhongwei, Ishima Tamaki, Pu Yaoyu, Hwang Sung Hee, Toyoshima Manabu, Iwayama Yoshimi, Hisano Yasuko, Yoshikawa Takeo, Hammock Bruce D., Hashimoto Kenji, Key role of soluble epoxide hydrolase in the neurodevelopmental disorders of offspring after maternal immune activation, Proceedings of the National Academy of Sciences, 116, 14, 2019. Crossref

  468. Amitai Nurith, Semenova Svetlana, Markou Athina, Cognitive-disruptive effects of the psychotomimetic phencyclidine and attenuation by atypical antipsychotic medications in rats, Psychopharmacology, 193, 4, 2007. Crossref

  469. Shin Hee-Sup, Kim Daesoo, Koh Hae-Young, Lack of barbering behavior in the phospholipase Cβ1 mutant mouse: a model animal for schizophrenia, in Neurobiology of Grooming Behavior, 2010. Crossref

  470. Bowins Brad, Depression: Discrete or Continuous?, Psychopathology, 48, 2, 2015. Crossref

  471. Bubeníková-Valešová Věra, Horáček Jiří, Vrajová Monika, Höschl Cyril, Models of schizophrenia in humans and animals based on inhibition of NMDA receptors, Neuroscience & Biobehavioral Reviews, 32, 5, 2008. Crossref

  472. Zhang Qi, He Hui, Cao Bo, Gao Rang, Jiang Liping, Zhang Xiangyang, Dai Jing, Analysis of cognitive impairment in schizophrenia based on machine learning: Interaction between psychological stress and immune system, Neuroscience Letters, 760, 2021. Crossref

  473. Amitai Nurith, Young Jared W., Higa Kerin, Sharp Richard F., Geyer Mark A., Powell Susan B., Isolation rearing effects on probabilistic learning and cognitive flexibility in rats, Cognitive, Affective, & Behavioral Neuroscience, 14, 1, 2014. Crossref

  474. Tan Yunfei, Fujita Yuko, Pu Yaoyu, Chang Lijia, Qu Youge, Wang Xinming, Hashimoto Kenji, Repeated intermittent administration of (R)-ketamine during juvenile and adolescent stages prevents schizophrenia-relevant phenotypes in adult offspring after maternal immune activation: a role of TrkB signaling, European Archives of Psychiatry and Clinical Neuroscience, 272, 4, 2022. Crossref

  475. Clayson Peter E., Molina Juan L., Joshi Yash B., Thomas Michael L., Sprock Joyce, Nungaray John, Swerdlow Neal R., Light Gregory A., Evaluation of the frequency following response as a predictive biomarker of response to cognitive training in schizophrenia, Psychiatry Research, 305, 2021. Crossref

  476. Pickard B S, Malloy M P, Christoforou A, Thomson P A, Evans K L, Morris S W, Hampson M, Porteous D J, Blackwood D H R, Muir W J, Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder, Molecular Psychiatry, 11, 9, 2006. Crossref

  477. Kargieman Lucila, Santana Noemí, Mengod Guadalupe, Celada Pau, Artigas Francesc, Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine, Proceedings of the National Academy of Sciences, 104, 37, 2007. Crossref

  478. Fénelon Karine, Mukai Jun, Xu Bin, Hsu Pei-Ken, Drew Liam J., Karayiorgou Maria, Fischbach Gerald D., MacDermott Amy B., Gogos Joseph A., Deficiency of Dgcr8 , a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex , Proceedings of the National Academy of Sciences, 108, 11, 2011. Crossref

  479. Horikoshi Sho, Shiga Tetsuya, Hoshino Hiroshi, Ochiai Haruka, Kanno-Nozaki Keiko, Kanno Kazuko, Kaneko Haruka, Kunii Yasuto, Miura Itaru, Yabe Hirooki, The Relationship between Mismatch Negativity and the <b><i>COMT</i></b>Val108/158Met Genotype in Schizophrenia, Neuropsychobiology, 77, 4, 2019. Crossref

  480. Li Xue, Yuan Xiuxia, Pang Lijuan, Zhang Siwei, Li Yajun, Huang Xufeng, Fan Xiaoduo, Song Xueqin, The effect of serum lipids and short-chain fatty acids on cognitive functioning in drug-naïve, first episode schizophrenia patients, Psychiatry Research, 313, 2022. Crossref

  481. Tsai Che-Wen, Tsai Shih-Jen, Pan Yi-Ju, Lin Hsin-Mei, Pan Tsung-Yu, Yang Feng-Yi, Transcranial Ultrasound Stimulation Reverses Behavior Changes and the Expression of Calcium-Binding Protein in a Rodent Model of Schizophrenia, Neurotherapeutics, 19, 2, 2022. Crossref

  482. Bagney Alexandra, Rodriguez-Jimenez Roberto, Martinez-Gras Isabel, Sanchez-Morla Eva Maria, Santos Jose Luis, Jimenez-Arriero Miguel Angel, Lobo Antonio, McGorry Patrick D., Palomo Tomas, Negative Symptoms and Executive Function in Schizophrenia: Does Their Relationship Change with Illness Duration?, Psychopathology, 46, 4, 2013. Crossref

  483. Tanaka S., Dopaminergic control of working memory and its relevance to schizophrenia: A circuit dynamics perspective, Neuroscience, 139, 1, 2006. Crossref

  484. Alpár Alán, Di Marzo Vincenzo, Harkany Tibor, At the Tip of an Iceberg: Prenatal Marijuana and Its Possible Relation to Neuropsychiatric Outcome in the Offspring, Biological Psychiatry, 79, 7, 2016. Crossref

  485. Anticevic Alan, Krystal John H., Barch Deanna M., Translational cognitive neuroscience of schizophrenia: bridging neurocognitive and computational approaches toward understanding cognitive deficits, in Cognitive Impairment in Schizophrenia, 2013. Crossref

  486. Genetic and biological contributions to cognitive impairment, in Cognitive Impairment in Schizophrenia, 2013. Crossref

  487. Characteristics of cognitive impairment in schizophrenia, in Cognitive Impairment in Schizophrenia, 2013. Crossref

  488. Russo Manuela, Murray Robin, Reichenberg Abraham, Cognitive impairment and symptom dimensions in psychosis, in Cognitive Impairment in Schizophrenia, 2013. Crossref

  489. Eggan Stephen M, Stoyak Samuel R, Verrico Christopher D, Lewis David A, Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder, Neuropsychopharmacology, 35, 10, 2010. Crossref

  490. Sheffield Julia M., Gold James M., Strauss Milton E., Carter Cameron S., MacDonald Angus W., Ragland J. Daniel, Silverstein Steven M., Barch Deanna M., Common and specific cognitive deficits in schizophrenia: relationships to function, Cognitive, Affective, & Behavioral Neuroscience, 14, 1, 2014. Crossref

  491. Reichenberg Abraham (Avi), The assessment of neuropsychological functioning in schizophrenia, Dialogues in Clinical Neuroscience, 12, 3, 2010. Crossref

  492. Song Jie, Yao Shuyang, Kowalec Kaarina, Lu Yi, Sariaslan Amir, Szatkiewicz Jin P., Larsson Henrik, Lichtenstein Paul, Hultman Christina M., Sullivan Patrick F., The impact of educational attainment, intelligence and intellectual disability on schizophrenia: a Swedish population-based register and genetic study, Molecular Psychiatry, 27, 5, 2022. Crossref

  493. Agrud Anass, Subburaju Sivan, Goel Pranay, Ren Jun, Kumar Ashwin Srinivasan, Caldarone Barbara J., Dai Wangde, Chavez Jesus, Fukumura Dai, Jain Rakesh K., Kloner Robert A., Vasudevan Anju, Gabrb3 endothelial cell-specific knockout mice display abnormal blood flow, hypertension, and behavioral dysfunction, Scientific Reports, 12, 1, 2022. Crossref

  494. Hashimoto T, Arion D, Unger T, Maldonado-Avilés J G, Morris H M, Volk D W, Mirnics K, Lewis D A, Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia, Molecular Psychiatry, 13, 2, 2008. Crossref

  495. Lin Yuhang, Du Peishan, Sun Hongze, Liang Yi, Wang Zeru, Cui Yan, Chen Ke, Xia Yang, Yao Dezhong, Yu Liang, Guo Daqing, Identifying Refractory Epilepsy Without Structural Abnormalities by Fusing the Common Spatial Patterns of Functional and Effective EEG Networks, IEEE Transactions on Neural Systems and Rehabilitation Engineering, 29, 2021. Crossref

  496. Papaleo F, Burdick M C, Callicott J H, Weinberger D R, Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans, Molecular Psychiatry, 19, 3, 2014. Crossref

  497. Wedenoja J, Loukola A, Tuulio-Henriksson A, Paunio T, Ekelund J, Silander K, Varilo T, Heikkilä K, Suvisaari J, Partonen T, Lönnqvist J, Peltonen L, Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families, Molecular Psychiatry, 13, 7, 2008. Crossref

  498. Miyakawa Tsuyoshi, Leiter Lorene M., Gerber David J., Gainetdinov Raul R., Sotnikova Tatyana D., Zeng Hongkui, Caron Marc G., Tonegawa Susumu, Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia, Proceedings of the National Academy of Sciences, 100, 15, 2003. Crossref

  499. Glausier J R, Fish K N, Lewis D A, Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects, Molecular Psychiatry, 19, 1, 2014. Crossref

  500. Llorca Pierre-Michel, Nuss Philippe, Fakra Éric, Alamome Isabelle, Drapier Dominique, El Hage Wissam, Jardri Renaud, Mouchabac Stéphane, Rabbani Marc, Simon Nicolas, Vacheron Marie-Noëlle, Azorin Jean-Michel, Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study, BMC Psychiatry, 22, 1, 2022. Crossref

  501. Clayson Peter E., Joshi Yash B., Thomas Michael L., Tarasenko Melissa, Bismark Andrew, Sprock Joyce, Nungaray John, Cardoso Lauren, Wynn Jonathan K., Swerdlow Neal R., Light Gregory A., The viability of the frequency following response characteristics for use as biomarkers of cognitive therapeutics in schizophrenia, Schizophrenia Research, 243, 2022. Crossref

  502. Meller Tina, Schmitt Simon, Stein Frederike, Brosch Katharina, Mosebach Johannes, Yüksel Dilara, Zaremba Dario, Grotegerd Dominik, Dohm Katharina, Meinert Susanne, Förster Katharina, Redlich Ronny, Opel Nils, Repple Jonathan, Hahn Tim, Jansen Andreas, Andlauer Till F.M., Forstner Andreas J., Heilmann-Heimbach Stefanie, Streit Fabian, Witt Stephanie H., Rietschel Marcella, Müller-Myhsok Bertram, Nöthen Markus M., Dannlowski Udo, Krug Axel, Kircher Tilo, Nenadić Igor, Associations of schizophrenia risk genes ZNF804A and CACNA1C with schizotypy and modulation of attention in healthy subjects, Schizophrenia Research, 208, 2019. Crossref

  503. Yabuki Yasushi, Wu Lei, Fukunaga Kohji, Cognitive enhancer ST101 improves schizophrenia-like behaviors in neonatal ventral hippocampus-lesioned rats in association with improved CaMKII/PKC pathway, Journal of Pharmacological Sciences, 140, 3, 2019. Crossref

  504. Fond G., Boyer L., Leboyer M., Godin O., Llorca P.M., Andrianarisoa M., Berna F., Brunel L., Aouizerate B., Capdevielle D., Chereau I., D'Amato T., Dubertret C., Dubreucq J., Faget C., Gabayet F., Mallet J., Misdrahi D., Rey R., Lancon C., Passerieux C., Roux P., Vidailhet P., Yazbek H., Schürhoff F., Bulzacka E., Andrianarisoa M., Aouizerate B., Berna F., Blanc O., Brunel L., Bulzacka E., Capdevielle D., Chereau-Boudet I., Chesnoy-Servanin G., Danion Jm, D'Amato T., Deloge A., Delorme C., Denizot H., Dorey J.M., Dubertret C., Dubreucq J., Faget C., Fluttaz C., Fond G., Fonteneau S., Gabayet F., Giraud-Baro E., Hardy-Bayle M.C., Lacelle D., Lançon C., Laouamri H., Leboyer M., Le Gloahec T., Le Strat Y., Llorca , Mallet J., Metairie E., Misdrahi D., Offerlin-Meyer I., Passerieux C., Peri P., Pires S., Portalier C., Rey R., Roman C., Sebilleau M., Schandrin A., Schurhoff F., Tessier A., Tronche Am, Urbach M., Vaillant F., Vehier A., Vidailhet P., Vilà E., Yazbek H., Zinetti-Bertschy A., Influence of Venus and Mars in the cognitive sky of schizophrenia. Results from the first-step national FACE-SZ cohort, Schizophrenia Research, 195, 2018. Crossref

  505. Veselinović Tanja, Neuner Irene, Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia, CNS Drugs, 36, 8, 2022. Crossref

  506. Wang Qian, Wang Meng-wei, Sun Yan-yun, Hu Xiao-yan, Geng Pan-pan, Shu Hui, Wang Xiao-na, Wang Hao, Zhang Jun-fang, Cheng Hong-qiang, Wang Wei, Jin Xin-chun, Nicotine pretreatment alleviates MK-801-induced behavioral and cognitive deficits in mice by regulating Pdlim5/CRTC1 in the PFC, Acta Pharmacologica Sinica, 2022. Crossref

  507. Greenwood Tiffany A., , 2022. Crossref

  508. Cortez Isadora Lopes, Silva Nicole R., Rodrigues Naielly S., Pedrazzi João Francisco C., Del Bel Elaine A., Mechoulam Raphael, Gomes Felipe V., Guimarães Francisco S., HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 117, 2022. Crossref

  509. Huang Lin-Jye, Hu Fu-Chang, Wu Chinyu, Yang Yi-Hong, Lee Shu-Chun, Huang Hsu-Chang, Yu Chun-Yi, Lai Kuan-Yu, Are the measurement structures of the Traditional Chinese Dispositional Flow Scale-2 equivalent between schizophrenic patients and healthy subjects?, Journal of the Formosan Medical Association, 121, 10, 2022. Crossref

  510. Eryilmaz Hamdi, Pax Melissa, O’Neill Alexandra G., Vangel Mark, Diez Ibai, Holt Daphne J., Camprodon Joan A., Sepulcre Jorge, Roffman Joshua L., Network hub centrality and working memory performance in schizophrenia, Schizophrenia, 8, 1, 2022. Crossref

  511. Murillo‐García Nancy, Díaz‐Pons Alexandre, Fernández‐Cacho Luis Manuel, Miguel‐Corredera Margarita, Martínez‐Barrio Sara, Ortiz‐García de la Foz Víctor, Neergaard Karl, Ayesa‐Arriola Rosa, A family study on first episode of psychosis patients: Exploring neuropsychological performance as an endophenotype, Acta Psychiatrica Scandinavica, 145, 4, 2022. Crossref

  512. Grotts Joseph H., Mead Meredith M., Rab Shayan, Walker Imani J., Choi Kristen R., Geospatial analysis of associations among mental health need, housing need, and involuntary psychiatric hospitalizations of people experiencing homelessness in Los Angeles County, Social Science & Medicine, 311, 2022. Crossref

  513. Canu Daniela, Ioannou Chara, Müller Katarina, Martin Berthold, Fleischhaker Christian, Biscaldi Monica, Beauducel André, Smyrnis Nikolaos, van Elst Ludger Tebartz, Klein Christoph, Evidence towards a continuum of impairment across neurodevelopmental disorders from basic ocular-motor tasks, Scientific Reports, 12, 1, 2022. Crossref

  514. Jung Kanghoon, Choi Youngjin, Kwon Hyung-Bae, Cortical control of chandelier cells in neural codes, Frontiers in Cellular Neuroscience, 16, 2022. Crossref

  515. Zhang Yuanyuan, Lin Yuhang, Qu Zhichuang, Zhang Zhi, Guo Daqing, Chen Xin, Shu Haifen, Yu Sixun, Identifying Patients with Epilepsy Having Depression/Anxiety Disorder Using Common Spatial Patterns of Functional EEG Networks, Journal of Medical and Biological Engineering, 42, 5, 2022. Crossref

  516. Dong Jianfeng, Chen Wen, Liu Nana, Chang Shujuan, Zhu Wei, Kang Jiuhong, NRG1 knockdown rescues PV interneuron GABAergic maturation deficits and schizophrenia behaviors in fetal growth restriction mice, Cell Death Discovery, 8, 1, 2022. Crossref

  517. Chiang Shih Kuang, Liu Wan-Yu, Hu Tsung-Ming, The effect of computerized working memory training on working memory and emotion perception for patients with chronic schizophrenia and normal cognition, Applied Neuropsychology: Adult, 2022. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain